Abass Alavi

Q: What Schools Are Affiliated With Abass Alavi

Abass Alavi is affiliated with the following schools: University of Southern Denmark, All India Institute of Medical Sciences, New Delhi, Tehran University of Medical Sciences, University of Pennsylvania

Abass Alavi's AcademicInfluence.com Rankings

Abass Alavi

Computer Science

#2226

World Rank

#2319

Historical Rank

Computer Graphics

#40

World Rank

#42

Historical Rank

Database

#279

World Rank

#291

Historical Rank

computer-science Degrees

Abass Alavi

Physics

#1880

World Rank

#2853

Historical Rank

Nuclear Physics

#29

World Rank

#47

Historical Rank

physics Degrees

Download Badge

Computer Science
Physics

Abass Alavi's Degrees

PhD Physics University of Pennsylvania

Why Is Abass Alavi Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Abass Alavi is an Iranian-American physician-scientist specializing in the field of molecular imaging, most notably in the imaging modality of positron emission tomography . In August 1976, he was part of the team that performed the first human PET studies of the brain and whole body using the radiotracer [18F]Fluorodeoxyglucose . Alavi holds the position of Professor of Radiology and Neurology, as well as Director of Research Education in the Department of Radiology at the University of Pennsylvania. Over a career spanning five decades, he has amassed over 2,300 publications and 60,000 citations, earning an h-index of 125 and placing his publication record in the top percentile of scientists.

(See a Problem?)

Abass Alavi's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. (1987) (4069)
Akt Stimulates Aerobic Glycolysis in Cancer Cells (2004) (1414)
The [18F]Fluorodeoxyglucose Method for the Measurement of Local Cerebral Glucose Utilization in Mane (1979) (1139)
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. (2001) (863)
Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. (2001) (621)
Complications and Validity of Pulmonary Angiography in Acute Pulmonary Embolism (1992) (538)
18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. (2002) (517)
Skeletal PET with 18F-Fluoride: Applying New Technology to an Old Tracer* (2007) (509)
The measurement of regional cerebral blood flow during the complex cognitive task of meditation: a preliminary SPECT study (2001) (466)
Glucose Metabolic Rate Kinetic Model Parameter Determination in Humans: The Lumped Constants and Rate Constants for [18F]Fluorodeoxyglucose and [11C]Deoxyglucose (1985) (452)
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates. (2005) (437)
Utility of FDG-PET scanning in lymphoma by WHO classification. (2003) (426)
Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. (2002) (391)
A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma (2013) (372)
Positron emission tomography in patients with glioma a predictor of prognosis (1988) (365)
18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. (2001) (347)
Ventilation-perfusion scintigraphy in the PIOPED study. Part II. Evaluation of the scintigraphic criteria and interpretations. (1993) (320)
Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck (1999) (300)
Analysis of brain and cerebrospinal fluid volumes with MR imaging. Part I. Methods, reliability, and validation. (1991) (294)
Chest radiographic findings in patients with acute pulmonary embolism: observations from the PIOPED Study. (1993) (284)
Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. (2009) (253)
Standardized uptake values of FDG: body surface area correction is preferable to body weight correction. (1994) (251)
The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants. (2001) (249)
Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. (1998) (249)
Comparison of triple‐negative and estrogen receptor‐positive/progesterone receptor‐positive/HER2‐negative breast carcinoma using quantitative fluorine‐18 fluorodeoxyglucose/positron emission tomography imaging parameters (2008) (245)
Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. (1995) (232)
18F-FDG Uptake in Lung, Breast, and Colon Cancers: Molecular Biology Correlates and Disease Characterization* (2009) (220)
Metoclopramide to treat gastroparesis due to diabetes mellitus: a double-blind, controlled trial. (1982) (219)
Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan. (2007) (218)
PET/MR imaging: technical aspects and potential clinical applications. (2013) (217)
Regional brain function in schizophrenia. I. A positron emission tomography study. (1987) (215)
Positron emission tomography imaging in nonmalignant thoracic disorders. (2002) (213)
The SNMMI Practice Guideline for Therapy of Thyroid Disease with 131I 3.0* (2012) (213)
Functional imaging of inflammatory diseases using nuclear medicine techniques. (2009) (212)
18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. (2004) (211)
Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET. (2005) (210)
Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. (2011) (202)
Whole-body FDG-PET imaging in the management of patients with cancer. (2002) (201)
Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET (2002) (200)
Combined MTOR and autophagy inhibition (2014) (199)
Progressive Nonfluent Aphasia: Language, Cognitive, and PET Measures Contrasted with Probable Alzheimer's Disease (1996) (199)
Mitotic Rate as a Predictor of Sentinel Lymph NodePositivity in Patients With Thin Melanomas (2004) (198)
F-18 FDG Uptake in the Large Arteries: A New Observation (2001) (198)
Clinicopathologic factors associated with false negative FDG–PET in primary breast cancer (2006) (195)
18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. (2002) (194)
Cerebral Blood Flow during Meditative Prayer: Preliminary Findings and Methodological Issues (2003) (193)
Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. (2000) (189)
Colonic dysfunction in diabetes mellitus. (1980) (182)
In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent. (1989) (182)
Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy. Part II. Aging and Alzheimer dementia. (1991) (181)
Dynamic imaging in mild traumatic brain injury: support for the theory of medial temporal vulnerability. (2002) (178)
Metabolic mapping of functional activity in human subjects with the [18F]fluorodeoxyglucose technique. (1981) (178)
Partial Volume Correction Strategies in PET. (2007) (177)
Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. (2005) (175)
Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers. (2000) (174)
Slowly progressive aphasia without generalized dementia: Studies with positron emission tomography (1986) (172)
Comprehensive analysis of the results of the PIOPED Study. Prospective Investigation of Pulmonary Embolism Diagnosis Study. (1995) (172)
Contralateral cerebellar hypometabolism following cerebral insult: A positron emission tomographic study (1984) (170)
Scintigraphic detection of acute gastrointestinal bleeding. (1977) (167)
Role of Modern Imaging Techniques for Diagnosis of Infection in the Era of 18F-Fluorodeoxyglucose Positron Emission Tomography (2008) (165)
Incidence of Sentinel Node Metastasis in Patients With Thin Primary Melanoma (#1 mm) With Vertical Growth Phase (2000) (163)
The Effect of Anxiety on Cortical Cerebral Blood Flow and Metabolism (1987) (161)
In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans. (1990) (160)
Prediction of survival by [18F]fluorodeoxyglucose positron emission tomography in patients with locally advanced non-small-cell lung cancer undergoing definitive chemoradiation therapy: results of the ACRIN 6668/RTOG 0235 trial. (2013) (160)
Detection of mesial temporal lobe hypoperfusion in patients with temporal lobe epilepsy by use of arterial spin labeled perfusion MR imaging. (2001) (159)
Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes. (2006) (157)
The importance of the location of fluorodeoxyglucose uptake in periprosthetic infection in painful hip prostheses (2002) (156)
Tissue plasminogen activator for the treatment of acute pulmonary embolism (1990) (153)
Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. (1993) (150)
The Mark IV system for radionuclide computed tomography of the brain. (1976) (150)
Effect of schizophrenia on frontotemporal activity during word encoding and recognition: a PET cerebral blood flow study. (2001) (148)
FDG Positron Emission Tomography in the Surveillance of Hepatic Tumors Treated with Radiofrequency Ablation (2003) (148)
Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features. (1995) (145)
Computerized tomography, magnetic resonance imaging, and positron emission tomography in the study of brain trauma. Preliminary observations. (1986) (145)
When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? (2013) (144)
Regional brain function in schizophrenia. II. Repeated evaluation with positron emission tomography. (1987) (143)
Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. (2004) (143)
Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease (2012) (142)
Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection? (2007) (141)
FDG-PET for diagnosing prosthetic joint infection: systematic review and metaanalysis (2008) (140)
Prognostic value of FDG PET imaging in malignant pleural mesothelioma. (1999) (140)
Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5 (2003) (139)
Positron emission tomography in aging and dementia: effect of cerebral atrophy. (1987) (138)
Comparison of CT, MR, and PET in Alzheimer's dementia and normal aging. (1989) (138)
Alzheimer's disease with prominent visual symptoms. Clinical and metabolic evaluation. (1989) (137)
Local Cerebral Blood Volume Response to Carbon Dioxide in Man (1978) (137)
Diagnostic Performance of FDG-PET, MRI, and Plain Film Radiography (PFR) for the Diagnosis of Osteomyelitis in the Diabetic Foot (2010) (136)
Use of 2-Deoxy-D[1-11C]Glucose for the Determination of Local Cerebral Glucose Metabolism in Humans: Variation within and between Subjects (1982) (136)
FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries (2008) (135)
Positron emission tomographic studies of sensory stimuli, cognitive processes and anxiety. (1983) (132)
Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma? (2004) (131)
Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism. (2007) (131)
Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trial. (1996) (130)
FDG-PET Imaging Can Diagnose Periprosthetic Infection of the Hip (2008) (129)
Positron emission tomography imaging of regional cerebral glucose metabolism. (1986) (129)
Persistent non-specific FDG uptake on PET imaging following hip arthroplasty (2002) (128)
Rapid normalization of osseous FDG uptake following traumatic or surgical fractures (2003) (128)
Radioimmunodetection of human tumor xenografts by monoclonal antibodies. (1983) (127)
Functional Imaging of Cancer with Emphasis on Molecular Techniques (2007) (127)
The radiation dosimetry of 2 [F-18]fluoro-2-deoxy-D-glucose in man. (1982) (125)
Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. (1989) (125)
Dual-Time Point FDG PET Imaging in the Evaluation of Pulmonary Nodules With Minimally Increased Metabolic Activity (2007) (124)
Impact of dual-time-point 18F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules (2008) (124)
Emerging role of radiolabeled nanoparticles as an effective diagnostic technique (2012) (123)
Regional cerebral glucose metabolism in late-life depression and Alzheimer disease: a preliminary positron emission tomography study. (1993) (123)
Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphoma. (1999) (123)
Structural and functional imaging of normal bone marrow and evaluation of its age-related changes. (2007) (122)
Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2‐18f‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography (1999) (121)
Comparison of radionuclide bone scans and magnetic resonance imaging in detecting spinal metastases. (1993) (121)
Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection (2003) (120)
Superiority of Iodine-123 Compared with Iodine-131 Scanning for Thyroid Remnants in Patients with Differentiated Thyroid Cancer (2001) (119)
Measurement of local cerebral glucose metabolism in man with 18F-2-fluoro-2-deoxy-d-glucose. (1977) (119)
Effects of age on dopamine transporters in healthy humans. (1999) (118)
Predictors of outcome after anterior temporal lobectomy (1994) (118)
Frontotemporal cerebral blood flow change during executive and declarative memory tasks in schizophrenia: a positron emission tomography study. (1998) (117)
Effect of 2 Psoriasis Treatments on Vascular Inflammation and Novel Inflammatory Cardiovascular Biomarkers: A Randomized Placebo-Controlled Trial (2018) (116)
FDG PET/CT in carcinoma of unknown primary (2009) (116)
Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging (2009) (115)
123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study. (2005) (113)
PET imaging for differentiating recurrent brain tumor from radiation necrosis. (2005) (112)
The pivotal role of FDG-PET/CT in modern medicine. (2014) (112)
Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states. (2007) (109)
Subcortical Metabolic Alterations in Partial Epilepsy (1990) (109)
Fundamentals of PET and PET/CT imaging (2011) (108)
FDG-PET Imaging in Primary Bilateral Adrenal Lymphoma: A Case Report and Review of the Literature (2005) (106)
Detection and global quantification of cardiovascular molecular calcification by fluoro18-fluoride positron emission tomography/computed tomography--a novel concept. (2011) (105)
Localization of gastrointestinal bleeding: superiority of 99mTc sulfur colloid compared with angiography. (1981) (104)
Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome (1990) (104)
Complementary Roles of Whole-Body Diffusion-Weighted MRI and 18F-FDG PET: The State of the Art and Potential Applications (2010) (103)
Local Cerebral Blood Volume Determined by Three‐Dimensional Reconstruction of Radionuclide Scan Data (1975) (103)
In vivo detection of stem cells grafted in infarcted rat myocardium. (2005) (101)
Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients (2011) (101)
Value of ventilation/perfusion scans versus perfusion scans alone in acute pulmonary embolism. (1992) (100)
Lymphoscintigraphy A Reliable Test for the Diagnosis of Lymphedema (1993) (99)
Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer (2007) (99)
Comparison of fluorodeoxyglucose positron emission tomography and (111)indium-white blood cell imaging in the diagnosis of periprosthetic infection of the hip. (2006) (97)
Thoracic aorta calcification but not inflammation is associated with increased cardiovascular disease risk: results of the CAMONA study (2016) (97)
A recovery coefficient method for partial volume correction of PET images (2009) (97)
Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [18F]EF1. (2000) (96)
18F-NaF and 18F-FDG as molecular probes in the evaluation of atherosclerosis (2018) (94)
Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders (2011) (94)
Guest editorial: the conception of FDG-PET imaging. (2002) (93)
Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries (2008) (92)
Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters. (1998) (92)
Incidental Detection of Colon Cancer by FDG Positron Emission Tomography in Patients Examined for Pulmonary Nodules (2002) (92)
Evaluation of Recurrent Squamous Cell Carcinoma of the Head and Neck with FDG Positron Emission Tomography (2001) (90)
Registration of three-dimensional MR and PET images of the human brain without markers. (1991) (89)
Can the standardized uptake value characterize primary brain tumors on FDG-PET? (1999) (89)
Ventilation-perfusion scintigraphy in the PIOPED study. Part I. Data collection and tabulation. (1993) (88)
Cerebral blood flow differences between long-term meditators and non-meditators (2010) (88)
Radioimmunotherapy of non-Hodgkin's lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response? (2003) (87)
Positron emission tomography and subcortical glucose metabolism in schizophrenia (1988) (87)
Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation (2006) (86)
The Effects of Estrogen, Progesterone, and C-erbB-2 Receptor States on 18F-FDG Uptake of Primary Breast Cancer Lesions (2007) (86)
Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas. (2004) (86)
LOCAL CEREBRAL BLOOD VOLUME IN HEAD‐INJURED PATIENTS. DETERMINATION BY EMISSION COMPUTED TOMOGRAPHY OF 99mTc‐LABELED RED CELLS (1980) (84)
Roles of Positron Emission Tomography With Fluorine-18-Deoxyglucose in the Detection of Local Recurrent and Distant Metastatic Sarcoma (2003) (84)
Electrogastrography in patients with gastroparesis and effect of long-term cisapride (1993) (84)
The efficacy of iodine-123-MIBG as a screening test for pheochromocytoma. (1994) (83)
Cerebral blood flow changes in limbic regions induced by unsolvable anagram tasks. (1996) (83)
FDG PET for Diagnosing Infection in Hip and Knee Prostheses: Prospective Study in 221 Prostheses and Subgroup Comparison With Combined 111In-Labeled Leukocyte/99mTc-Sulfur Colloid Bone Marrow Imaging in 88 Prostheses (2014) (83)
New treatments and imaging strategies in degenerative disease of the intervertebral disks. (2012) (83)
Successful lymph node transplantation in rats, with restoration of lymphatic function. (1979) (83)
Quantitative assessment of the atherosclerotic burden of the aorta by combined FDG-PET and CT image analysis: a new concept. (2006) (82)
A new dimension of FDG-PET interpretation: assessment of tumor biology (2011) (81)
The Evolving Role of FDG-PET/CT in the Diagnosis, Staging, and Treatment of Breast Cancer (2019) (81)
Unparalleled contribution of 18F-FDG PET to medicine over 3 decades. (2008) (81)
Assessment of age-related changes in abdominal organ structure and function with computed tomography and positron emission tomography. (2007) (81)
Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: a novel approach with fluorodeoxyglucose-PET (2008) (81)
F-18 FDG-PET imaging and correlation with CT in staging and follow-up of pediatric lymphomas (2006) (81)
Delayed 18F-fluorodeoxyglucose PET/CT imaging improves quantitation of atherosclerotic plaque inflammation: Results from the CAMONA study (2014) (80)
FDG PET positive lymph nodes are highly predictive of metastasis in breast cancer (2006) (79)
Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET. (1987) (79)
Dynamic Changes of FDG Uptake and Clearance in Normal Tissues (2013) (78)
Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). (2012) (77)
The role of positron emission tomography with fluorine-18-deoxyglucose in identifying colorectal cancer metastases to liver (2000) (77)
Ipsilateral and contralateral thalamic hypometabolism as a predictor of outcome after temporal lobectomy for seizures. (2000) (77)
Ventilation-perfusion lung scanning in the evaluation of pulmonary hypertension. (1994) (76)
Effect of water and fat on gastric emptying of solid meals. (1979) (75)
18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia. (1982) (74)
Temporal profile of fluorodeoxyglucose uptake in malignant lesions and normal organs over extended time periods in patients with lung carcinoma: implications for its utilization in assessing malignant lesions. (2009) (74)
Insights into the Dose–Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases (2016) (74)
Role of FDG-PET in the Clinical Management of Paraneoplastic Neurological Syndrome: Detection of the Underlying Malignancy and the Brain PET-MRI Correlates (2008) (74)
Implications of PET based molecular imaging on the current and future practice of medicine. (2004) (74)
Right and left ventricular volume and ejection fraction by tomographic gated blood-pool scintigraphy. (1997) (73)
A Phase IV, Randomized, Double-Blind, Placebo-Controlled Crossover Study of the Effects of Ustekinumab on Vascular Inflammation in Psoriasis (the VIP-U trial). (2020) (73)
Role of Optimal Quantification of FDG PET Imaging in the Clinical Practice of Radiology. (2016) (72)
Metabolic and clinical correlates of acute ischemic infarction (1987) (72)
18FDG-positron emission tomography (PET) has a role to play in the diagnosis and therapy of infective endocarditis and cardiac device infection. (2013) (72)
Degree of Tumor FDG Uptake Correlates with Proliferation Index in Triple Negative Breast Cancer (2010) (72)
18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas. (2004) (71)
18F-FDG PET in malignant lymphoma: significance of positive findings (2005) (70)
F-18 FDG-PET/CT Evaluation of Patients With Differentiated Thyroid Cancer With Negative I-131 Total Body Scan and High Thyroglobulin Level (2009) (70)
PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog. (2004) (69)
Language comprehension and regional cerebral defects in frontotemporal degeneration and Alzheimer's disease (1998) (69)
Sarcoidosis demonstrated by FDG PET imaging with negative findings on gallium scintigraphy. (2005) (69)
FDG PET/CT in Crohn’s disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity (2014) (69)
Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer (2002) (69)
Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement (2007) (68)
Current status of sentinel lymph-node biopsy in patients with breast cancer (2011) (68)
Pretreatment 18F-FDG PET Textural Features in Locally Advanced Non–Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235 (2016) (68)
Evolving Role of Molecular Imaging with 18F-Sodium Fluoride PET as a Biomarker for Calcium Metabolism (2016) (67)
Current Evidence Base of FDG-PET/CT Imaging in the Clinical Management of Malignant Pleural Mesothelioma: Emerging Significance of Image Segmentation and Global Disease Assessment (2011) (67)
Significance of incidental fluorodeoxyglucose uptake in the parotid glands and its impact on patient management (2008) (67)
Age-related structural and metabolic changes in the pelvic reproductive end organs. (2007) (66)
PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain. (1995) (66)
Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer. (2005) (65)
Amyloid-β positron emission tomography imaging probes: a critical review. (2013) (65)
A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET/CT: a pilot study. (2013) (65)
FDG-PET Findings in Patients With Suspected Encephalitis (2004) (65)
Constraints on the cerebral basis for semantic processing from neuroimaging studies of Alzheimer’s disease (1997) (65)
Prognostic Significance of FDG PET/CT on the Follow-Up of Patients of Differentiated Thyroid Carcinoma With Negative 131I Whole-Body Scan and Elevated Thyroglobulin Levels: Correlation With Clinical and Histopathologic Characteristics and Long-Term Follow-Up Data (2012) (65)
Head-to-Head Comparison of Chest X-Ray/Head and Neck MRI, Chest CT/Head and Neck MRI, and 18F-FDG PET/CT for Detection of Distant Metastases and Synchronous Cancer in Oral, Pharyngeal, and Laryngeal Cancer (2017) (64)
Recent advances in pulmonary imaging. (1999) (64)
New noninvasive tests for Helicobacter pylori gastritis. Comparison with tissue-based gold standard. (1996) (64)
Oncologic PET tracers beyond [(18)F]FDG and the novel quantitative approaches in PET imaging. (2008) (63)
The characterization of IBF as a new selective dopamine D-2 receptor imaging agent. (1990) (63)
Mapping of functional activity in brain with 18F-fluoro-deoxyglucose. (1981) (62)
18F‐fluorodeoxyglucose–positron emission tomography in evaluation of primary cutaneous lymphoma (2006) (62)
Positron Emission Tomography in Evaluation of Dementia (2001) (62)
An update on the role of PET/CT and PET/MRI in ovarian cancer (2017) (62)
Cognitive and Physiological Substrates of Impaired Sentence Processing in Parkinson's Disease (1993) (61)
An update on novel quantitative techniques in the context of evolving whole-body PET imaging. (2015) (61)
Pretreatment FDG-PET metrics in stage III non-small cell lung cancer: ACRIN 6668/RTOG 0235. (2015) (61)
The Clinical Role of Fusion Imaging Using PET, CT, and MR Imaging. (2008) (61)
Indium-111-labeled white blood cells in the detection of osteomyelitis complicated by a pre-existing condition. (1988) (61)
PET: a revolution in medical imaging. (2004) (61)
Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging. (2003) (60)
Bone and marrow imaging in sickle cell disease: diagnosis of infarction. (1976) (60)
Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer? (2007) (59)
Radioimmunodetection of human glioma xenografts by monoclonal antibody to epidermal growth factor receptor. (1987) (59)
Quantification in PET. (2004) (59)
New grading system of cerebral gliomas using positron emisson tomography with F-18 fluorodeoxyglucose (1991) (59)
Treatment of recurrent or progressive malignant glioma with a recombinant adenovirus expressing human interferon-beta (H5.010CMVhIFN-beta): a phase I trial. (2001) (59)
Molecular imaging (PET) of brain tumors. (2009) (59)
Cerebral metabolism and patterned visual Stimulation (1988) (58)
Usefulness of noninvasive diagnostic tools for diagnosis of acute pulmonary embolism in patients with a normal chest radiograph. (1991) (58)
Feasibility and performance of novel software to quantify metabolically active volumes and 3D partial volume corrected SUV and metabolic volumetric products of spinal bone marrow metastases on 18F-FDG-PET/CT. (2011) (58)
Fluorodeoxyglucose-PET in the management of breast cancer. (2004) (58)
The Value of Radiologic Interventions and 18F-DOPA PET in Diagnosing and Localizing Focal Congenital Hyperinsulinism: Systematic Review and Meta-Analysis (2012) (58)
Concurrent CBF and CMRGlc changes during human brain activation by combined fMRI–PET scanning (2005) (57)
Oncogene pathway activation in mammary tumors dictates FDG-PET uptake. (2014) (57)
Pulmonary arterial hypertension: value of perfusion scintigraphy. (1987) (57)
The Role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Left-sided Endocarditis: Native vs Prosthetic Valves Endocarditis (2019) (56)
A cognitive-motor network demonstrated by positron emission tomography (1983) (55)
Effect of blood glucose level on standardized uptake value (SUV) in 18F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements (2018) (55)
Quantitative assessment of global lung inflammation following radiation therapy using FDG PET/CT: a pilot study (2014) (55)
Neuroimaging in patients with head injury. (2003) (55)
Is there a role for FDG PET imaging in the management of patients with sarcoidosis? (1994) (55)
Phase I radioimmunotherapy trial with iodine-131--labeled humanized MN-14 anti-carcinoembryonic antigen monoclonal antibody in patients with metastatic gastrointestinal and colorectal cancer. (2002) (55)
A Randomized Placebo Controlled Trial of Secukinumab on Aortic Vascular Inflammation in Moderate to Severe Plaque Psoriasis (VIP-S). (2020) (54)
I-123 iofetamine single-photon computed emission tomography in rapid cycling bipolar disorder: A clinical study (1997) (54)
Lateralized Changes in Regional Cerebral Blood Flow during Performance of Verbal and Facial Recognition Tasks: Correlations with Performance and “Effort” (1997) (54)
Detection of gastrointestinal bleeding with 99mTc-sulfur colloid. (1982) (54)
Standardized Uptake Values of Normal Breast Tissue with 2-Deoxy-2-[F-18]Fluoro-d-glucose Positron Emission Tomography: Variations with Age, Breast Density, and Menopausal Status (2006) (53)
Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic β-cell mass with positron emission tomography (PET) (2004) (53)
PET imaging in the assessment of normal and impaired cognitive function. (2005) (53)
Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial (2017) (53)
Clinical Utility of FDG–PET and PET/CT in Non-malignant Thoracic Disorders (2011) (53)
Episodic neurologic dysfunction with migraine and reversible imaging findings after radiation (2006) (53)
Potential of Dual Time Point FDG-PET Imaging in Differentiating Malignant from Benign Pleural Disease (2009) (53)
PET in the management of urologic malignancies. (2004) (53)
Fluorodeoxyglucose-PET in the management of malignant melanoma. (2005) (52)
In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans. (2005) (52)
Imaging in vivo herpes simplex virus thymidine kinase gene transfer to tumour-bearing rodents using positron emission tomography and [18F]FHPG (2001) (52)
Cerebral blood flow effects of pain and acupuncture: a preliminary single-photon emission computed tomography imaging study. (2005) (52)
Paraneoplastic Encephalitis Associated With Cystic Teratoma Is Detected by Fluorodeoxyglucose Positron Emission Tomography With Negative Magnetic Resonance Image Findings (2003) (52)
Initial Clinical Comparison of 18F-Florbetapir and 18F-FDG PET in Patients with Alzheimer Disease and Controls (2012) (51)
False Lateralization of Temporal Lobe Epilepsy with FDG Positron Emission Tomography (1995) (51)
[18F]Fluorodeoxyglucose (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) in Suspected Recurrent Breast Cancer: A Prospective Comparative Study of Dual-Time-Point FDG-PET/CT, Contrast-Enhanced CT, and Bone Scintigraphy. (2016) (51)
Chronic Stress-Related Neural Activity Associates With Subclinical Cardiovascular Disease in Psoriasis: A Prospective Cohort Study. (2020) (51)
The Role of PET in Evaluating Atherosclerosis: A Critical Review. (2018) (51)
Determination of age-related changes in structure and function of skin, adipose tissue, and skeletal muscle with computed tomography, magnetic resonance imaging, and positron emission tomography. (2007) (50)
Muscarinic blockade inhibits gastric emptying of mixed-nutrient meal: effects of weight and gender. (1999) (50)
Improved radioimmunoimaging of human tumor xenografts by a mixture of monoclonal antibody F(ab')2 fragments. (1986) (50)
Dual-time-point Imaging and Delayed-time-point Fluorodeoxyglucose-PET/Computed Tomography Imaging in Various Clinical Settings. (2016) (50)
Thyroid imaging with high-field-strength surface-coil MR. (1987) (50)
Ischemic lesions of the occipital cortex and optic radiations (1985) (50)
Global disease score (GDS) is the name of the game! (2019) (49)
Positron emission tomography in two cases of childhood epileptic encephalopathy (Lennox‐Gastaut syndrome) (1982) (49)
Emerging optical and nuclear medicine imaging methods in rheumatoid arthritis (2012) (49)
Clinical evaluation of processing techniques for attenuation correction with 137Cs in whole-body PET imaging. (1999) (49)
Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent. (2004) (48)
FDG PET in Detecting Primary and Recurrent Malignant Salivary Gland Tumors (2007) (48)
Technetium-99m-HMPAO SPECT in partial status epilepticus. (1994) (48)
Delayed sodium 18F-fluoride PET/CT imaging does not improve quantification of vascular calcification metabolism: Results from the CAMONA study (2014) (48)
Planar and SPECT imaging in the era of PET and PET–CT: can it survive the test of time? (2008) (48)
Diffuse bone marrow accumulation of FDG in a patient with chronic myeloid leukemia mimics hematopoietic cytokine-mediated FDG uptake on positron emission tomography. (2004) (48)
Determination of regional cerebral function with FDG-PET imaging in neuropsychiatric disorders. (2002) (48)
Normal variants in [18F]-fluorodeoxyglucose PET imaging. (2004) (48)
Impact of Personal Characteristics and Technical Factors on Quantification of Sodium 18F-Fluoride Uptake in Human Arteries: Prospective Evaluation of Healthy Subjects (2015) (47)
Advances in Attenuation Correction Techniques in PET. (2007) (47)
Validation studies of iodine-123-iodoamphetamine as a cerebral blood flow tracer using emission tomography. (1990) (46)
Catheter-Related Focal FDG Activity on Whole Body PET Imaging (2004) (46)
Divergent determinants of 18F–NaF uptake and visible calcium deposition in large arteries: relationship with Framingham risk score (2014) (46)
Regional Differences in the Coupling between Resting Cerebral Blood Flow and Metabolism may Indicate Action Preparedness as a Default State (2008) (46)
Unraveling Vascular Inflammation: From Immunology to Imaging. (2017) (46)
The role of molecular imaging in diagnosis of deep vein thrombosis. (2014) (46)
Non-FDG PET in the practice of oncology. (2010) (46)
Active Macromolecule Uptake by Lymph Node Antigen-Presenting Cells: A Novel Mechanism in Determining Sentinel Lymph Node Status (2000) (45)
81-Fluorodeoxyglucose Positron Emission Tomography as a Novel Imaging Tool for the Diagnosis of Aortoenteric Fistula and Aortic Graft Infection (2003) (45)
F-18 FDG positron emission tomography demonstrates resolution of non-Hodgkin's lymphoma of the parotid gland in a patient with Sjogren's syndrome: before and after anti-CD20 antibody rituximab therapy. (2002) (45)
PET imaging in gynecologic malignancies. (2004) (45)
Prognostic Implication of Dual-Phase PET in Adenocarcinoma of the Lung (2010) (45)
PET evaluation of therapeutic limb perfusion in Merkel's cell carcinoma. (1998) (44)
Structural and functional imaging correlates for age-related changes in the brain. (2007) (44)
Recovery of vision after ischemic lesions: Positron emission tomography (1987) (44)
Assessment of atherosclerosis in large vessel walls: A comprehensive review of FDG-PET/CT image acquisition protocols and methods for uptake quantification (2015) (44)
Intense fluorodeoxyglucose activity in pulmonary amyloid lesions on positron emission tomography. (2003) (44)
Radiolabeled antifibrin antibody in the detection of venous thrombosis: preliminary results. (1990) (44)
Quantitative Assessment of the Hepatic Metabolic Volume Product in Patients with Diffuse Hepatic Steatosis and Normal Controls Through Use of FDG-PET and MR Imaging: A Novel Concept (2010) (43)
Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise. (2017) (43)
PET, CT, and MRI in the Evaluation of Neuropshychiatric Disorder: Current Applications (1989) (43)
Technetium-99m stannous phytate as an imaging agent for lymph nodes. (1978) (43)
18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis. (2019) (43)
Accuracy of F-18 fluorodeoxyglucose positron emission tomography for the evaluation of malignancy in patients presenting with new lung abnormalities: a retrospective review. (2001) (43)
The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis (2017) (43)
Magnetic Resonance Imaging Based Bone Marrow Segmentation for Quantitative Calculation of Pure Red Marrow Metabolism Using 2-Deoxy-2-[F-18]fluoro-d-glucose- Positron Emission Tomography: a Novel Application with Significant Implications for Combined Structure–Function Approach (2007) (43)
Iatrogenic Artifacts on Whole-Body F-18 FDG PET Imaging (2004) (42)
Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography. (1982) (42)
Radiation-induced esophagitis on FDG PET imaging. (2003) (42)
Implications of Standardized Uptake Value Measurements of the Primary Lesions in Proven Cases of Breast Carcinoma with Different Degree of Disease Burden at Diagnosis: Does 2-Deoxy-2-[F-18]fluoro-d-glucose-Positron Emission Tomography Predict Tumor Biology? (2007) (42)
Clinical impact of FDG-PET/CT on colorectal cancer staging and treatment strategy. (2014) (42)
Evaluation of 18F-FDG PET and MRI Associations in Pediatric Diffuse Intrinsic Brain Stem Glioma: A Report from the Pediatric Brain Tumor Consortium (2011) (42)
Clinical applications of fluorodeoxyglucose-positron emission tomography in the management of malignant melanoma (2005) (42)
Can [18F]fluorodeoxyglucose positron emission tomography imaging complement biopsy results from the iliac crest for the detection of bone marrow involvement in patients with malignant lymphoma? (2006) (42)
An update on the role of 18F-FDG-PET/CT in major infectious and inflammatory diseases. (2019) (41)
FDG PET/CT methodology for evaluation of treatment response in lymphoma: from “graded visual analysis” and “semiquantitative SUVmax” to global disease burden assessment (2014) (41)
(18)F-NaF PET Imaging of Early Coronary Artery Calcification. (2016) (41)
Assessment of vulnerable atherosclerotic and fibrotic plaques in coronary arteries using (68)Ga-DOTATATE PET/CT. (2015) (41)
Management of osteonecrosis in sickle-cell anemia and its genetic variants. (1978) (41)
Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia (2018) (41)
Positron emission tomographic studies of perceptual tasks (1984) (40)
Regional distribution and kinetics of haloperidol binding in human brain: A pet study with [18F]haloperidol (1992) (40)
PET regional cerebral blood flow change during working and declarative memory: relationship with task performance. (1997) (40)
99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma. (1999) (40)
Demonstration of increased FDG activity in Rosai-Dorfman disease on positron emission tomography. (2004) (39)
Synthesis and evaluation of fluorine-18 labeled glyburide analogs as beta-cell imaging agents. (2004) (39)
A detailed evaluation of patients with acute pulmonary embolism and low- or very-low-probability lung scan interpretations. (1993) (39)
Nuclear imaging methods for non-invasive drug monitoring. (2000) (39)
Lung scanning in the diagnosis of pulmonary embolism: the emperor redressed. (1991) (39)
Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow. (2004) (39)
Amyloid-β imaging with PET in Alzheimer’s disease: is it feasible with current radiotracers and technologies? (2012) (38)
Cerebral Blood Flow with the Continuous Infusion of Oxygen-15-Labeled Water (1985) (38)
SUVmax of 2.5 should not be embraced as a magic threshold for separating benign from malignant lesions (2013) (38)
Comparison of I-123 and I-131 for Whole-Body Imaging After Stimulation by Recombinant Human Thyrotropin: A Preliminary Report (2003) (38)
Gallium-67-citrate scanning in the assessment of disease activity in sarcoidosis. (1992) (38)
Cholescintigraphy in the diagnosis of acute cholecystitis: morphine augmentation is superior to delayed imaging. (1993) (38)
SPECT and PET imaging of brain tumors. (1999) (38)
What can be and what cannot be accomplished with PET to detect and characterize atherosclerotic plaques (2018) (37)
Role of radionuclide imaging in trials of antiangiogenic therapy. (2000) (37)
Characterization of the Electroanatomic Substrate in Cardiac Sarcoidosis: Correlation With Imaging Findings of Scar and Inflammation. (2017) (37)
Positron emission tomographic studies of local cerebral glucose metabolism in humans in physiological and pathophysiological conditions. (1983) (37)
Demonstration of Excessive Metabolic Activity of Thoracic and Abdominal Muscles on FDG-PET in Patients With Chronic Obstructive Pulmonary Disease (2005) (37)
Computed tomography of intracerebral hematomas. II. Radionuclide and transmission CT studies of the perihematoma region. (1977) (37)
Age-Related Changes in the Metabolic Activity and Distribution of the Red Marrow as Demonstrated by 2-Deoxy-2-[F-18]fluoro-d-glucose-Positron Emission Tomography (2007) (37)
Potential clinical utility of dual time point FDG-PET for distinguishing benign from malignant lesions: implications for oncological imaging. (2009) (37)
Evolving concept of imaging bone marrow metastasis in the twenty-first century: critical role of FDG-PET (2008) (37)
Multiple ectopic lesions of focal islet adenomatosis identified by positron emission tomography scan in an infant with congenital hyperinsulinism. (2007) (37)
2-Deoxy-2-[F-18]fluoro-D-glucose-Positron Emission Tomography in Characterization of Solid Renal Masses (2005) (37)
Comparison of PASL, PCASL, and background‐suppressed 3D PCASL in mild cognitive impairment (2017) (36)
Coronary fluorine-18-sodium fluoride uptake is increased in healthy adults with an unfavorable cardiovascular risk profile: results from the CAMONA study (2017) (36)
Application of Partial Volume Effect Correction and 4D PET in the Quantification of FDG Avid Lung Lesions (2015) (36)
A new myocardial imaging agent: synthesis, characterization, and biodistribution of gallium-68-BAT-TECH. (1990) (36)
Critical role of 18F-labeled fluorodeoxyglucose PET in the management of patients with arthroplasty. (2007) (36)
Potential applications of PET imaging in developing novel cancer therapies. (1999) (36)
The effect of breathing irregularities on quantitative accuracy of respiratory gated PET∕CT. (2011) (36)
Assessment of tumor burden and treatment response by 18F-fluorodeoxyglucose injection and positron emission tomography in patients with cutaneous T- and B-cell lymphomas. (2002) (36)
[(124)I]FIAU: Human dosimetry and infection imaging in patients with suspected prosthetic joint infection. (2016) (36)
Delayed time-point 18F-FDG PET CT imaging enhances assessment of atherosclerotic plaque inflammation (2013) (36)
The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression (2008) (35)
Feasibility of Automated Partial-Volume Correction of SUVs in Current PET/CT Scanners: Can Manufacturers Provide Integrated, Ready-to-Use Software? (2008) (35)
Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer. (2016) (34)
Assessment of age-related morphological and functional changes of selected structures of the head and neck by computed tomography, magnetic resonance imaging, and positron emission tomography. (2007) (34)
Paraneoplastic cerebellar degeneration: Yo-expressing tumor revealed after a 5-year follow-up with FDG-PET (2006) (34)
F-18 FDG positron emission tomography in non-Hodgkin lymphoma of the breast. (2005) (34)
Positron emission tomography imaging in evaluation of cancer patients. (2003) (34)
Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson’s disease (2005) (34)
Increased 18F-FDG uptake within the reticuloendothelial system in patients with active lung cancer on PET imaging may indicate activation of the systemic immune response. (2010) (34)
PET, CT, and MRI in the evaluation of neuropsychiatric disorders: current applications. (1989) (34)
Intense esophageal FDG activity caused by Candida infection obscured the concurrent primary esophageal cancer on PET imaging. (2005) (34)
Atherosclerosis imaging with 18F-sodium fluoride PET: state-of-the-art review (2019) (34)
18-fluorodeoxyglucose positron emission tomography as a novel imaging tool for the diagnosis of aortoenteric fistula and aortic graft infection--a case report. (2003) (34)
Detection of chronic recurrent lower extremity deep venous thrombosis on fluorine-18 fluorodeoxyglucose positron emission tomography. (2000) (33)
Facet joint arthropathy demonstrated on FDG-PET. (2006) (33)
Gd3+-DTPA-DG: novel nanosized dual anticancer and molecular imaging agent (2011) (33)
Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies (2007) (33)
N-(N-Benzylpiperidin-4-yl)-2-[18F]fluorobenzamide: A potential ligand for PET imaging of σ receptors (1997) (33)
Aortic vascular inflammation in psoriasis is associated with HDL particle size and concentration: a pilot study. (2012) (32)
Risk Stratification of Patients With Apparently Idiopathic Premature Ventricular Contractions: A Multicenter International CMR Registry. (2020) (32)
Gallium-67 scans in children with solid tumors. (1976) (32)
Use of PET and Other Functional Imaging to Guide Target Delineation in Radiation Oncology. (2018) (32)
Scan detection of bone marrow infarcts in sickle cell disorders. (1974) (32)
Indium‐111 leukocyte scintigraphic detection of subclinical osteomyelitis complicating delayed and nonunion long bone fractures: A prospective study (1987) (32)
GC-ASM: Synergistic integration of graph-cut and active shape model strategies for medical image segmentation (2013) (32)
Comparison of FDG-PET, MRI and CT for post radiofrequency ablation evaluation of hepatic tumors (2012) (32)
Synthesis and in vitro evaluation of (S)-2-([11C]methoxy)-4-[3-methyl-1-(2-piperidine-1-yl-phenyl)-butyl-carbamoyl]-benzoic acid ([11C]methoxy-repaglinide): a potential beta-cell imaging agent. (2004) (32)
Chronic cholecystitis detected by FDG-PET. (2004) (31)
Hemispheric Activation of Anterior and Inferior Prefrontal Cortex during Verbal Encoding and Recognition: A PET Study of Healthy Volunteers (2000) (31)
A simplified one-pot synthesis of 9-[(3-[18F]fluoro-1-hydroxy-2-propoxy)methyl]guanine([18F]FHPG) and 9-(4-[18F]fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG) for gene therapy. (2001) (31)
Radiation myelopathy visualized as increased FDG uptake on positron emission tomography. (2005) (31)
Imaging of lower extremity artery atherosclerosis in diabetic foot: FDG-PET imaging and histopathological correlates. (2007) (31)
Acute bronchitis imaged with F-18 FDG positron emission tomography. (2003) (31)
Current Trends in PET and Combined (PET/CT and PET/MR) Systems Design. (2007) (31)
Bone marrow and not bone is the primary site for skeletal metastasis: critical role of [18F]fluorodeoxyglucose positron emission tomography in this setting. (2007) (30)
PET and PET–CT imaging of gynecological malignancies: present role and future promise (2009) (30)
The role of cimetidine-enhanced technetium-99m-pertechnetate imaging for visualizing Meckel's diverticulum. (1991) (30)
Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis (2000) (30)
Investigation of thyroid, head, and neck cancers with PET. (2004) (30)
Neuroimaging of Acupuncture in Patients with Chronic Pain (1997) (30)
Regional cerebral glucose metabolism in healthy volunteers determined by fluordeoxyglucose positron emission tomography: appearance and variance in the transaxial, coronal, and sagittal planes. (2000) (30)
Comparison of 123I scintigraphy at 5 and 24 hours in patients with differentiated thyroid cancer. (2002) (30)
PET-Based Personalized Management in Clinical Oncology: An Unavoidable Path for the Foreseeable Future. (2016) (30)
The Effects of Aging on Testicular Volume and Glucose Metabolism: an Investigation with Ultrasonography and FDG-PET (2011) (30)
Tc-99m Sulfur Colloid and Tc-99m Tagged Red Blood Cell Methods Are Comparable for Detecting Lower Gastrointestinal Bleeding in Clinical Practice (2002) (30)
Standardized uptake value as an unreliable index of renal disease on fluorodeoxyglucose PET imaging. (2000) (30)
Is PET-CT the only option? (2007) (30)
Cerebral metabolic changes associated with Lyme disease (2002) (30)
Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings (2014) (29)
Chronic synovitis with early cartilage destruction in sickle cell disease. (1977) (29)
FDG-PET findings in patients with galactosaemia (2008) (29)
A DETAILED ANALYSIS OF PATIENTS WITH METCHED VENTILATION‐PERFUSION DEFECTS AND CHEST RADIOGRAPHIC OPACITY (1993) (29)
Cancer metastasizes to the bone marrow and not to the bone: time for a paradigm shift! (2018) (29)
F-18 FDG Uptake in a Patient with Psoriatic Arthritis: Imaging Correlation with Patient Symptoms (2001) (29)
The clinical role of fusion imaging using PET, CT, and MR imaging. (2010) (29)
Positron emission tomography to study the effect of eye closure and optic nerve damage on human cerebral glucose metabolism. (1989) (29)
A case series study of the neurophysiological effects of altered states of mind during intense Islamic prayer (2015) (29)
Labeling monoclonal antibodies and F(ab')2 fragments with (111In) indium using cyclic DTPA anhydride and their in vivo behavior in mice bearing human tumor xenografts. (1984) (29)
Finding infection—help from PET (2001) (29)
Correction for Partial Volume Effect Is a Must, Not a Luxury, to Fully Exploit the Potential of Quantitative PET Imaging in Clinical Oncology (2018) (29)
Role of bone scintigraphy in the evaluation and treatment of nonunited fractures: concise communication. (1980) (29)
Emerging Standards and the Hybrid Model for Organizing Scientific Events During and After the COVID-19 Pandemic (2020) (28)
Quantitative Assessment of FDG Uptake in Brown Fat Using Standardized Uptake Value and Dual-Time-Point Scanning (2008) (28)
Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility (2009) (28)
Positron emission tomography in the investigation of central nervous system disorders. (1988) (28)
The Role of Imaging Techniques to Define a Peri-Prosthetic Hip and Knee Joint Infection: Multidisciplinary Consensus Statements (2020) (28)
Potential false-positive FDG PET imaging caused by subcutaneous radiotracer infiltration. (2003) (28)
Brain metabolism in the cerebellum and visual cortex correlates with neuropsychological testing in patients with Alzheimer's disease (2003) (28)
The effect of focal cerebral atrophy in positron emission tomographic studies of aging and dementia. (1990) (28)
Relationships between verbal memory performance and the cerebral distribution of fluorodeoxyglucose in patients with schizophrenia (1996) (28)
Multi-modal assessment in Alzheimer's disease. ADL in relation to PET, MRI and neuropsychology. (1995) (27)
The role of PET imaging in the management of patients with central nervous system disorders. (2005) (27)
Clinical Nononcologic Applications of PET/CT and PET/MRI in Musculoskeletal, Orthopedic, and Rheumatologic Imaging. (2018) (27)
Effects of soup preloads on gastric emptying and fullness ratings following an egg sandwich meal (1994) (27)
Assessing global cardiovascular molecular calcification with 18F-fluoride PET/CT: will this become a clinical reality and a challenge to CT calcification scoring? (2012) (27)
Differentiation of Bone and Bone Marrow Infarcts from Osteomyelitis in Sickle Cell Disorders (1989) (26)
Nonprosthesis orthopedic applications of (18)F fluoro-2-deoxy-D-glucose PET in the detection of osteomyelitis. (2007) (26)
Cerebral HMPAO spect in patients with major depression and healthy volunteers (1996) (26)
PET in pediatric diseases. (2005) (26)
Metabolic activity of the tongue in obstructive sleep apnea. A novel application of FDG positron emission tomography imaging. (2014) (26)
Sentinel lymph node biopsy in multifocal and multicentric breast cancer. (2004) (26)
Sequential technetium‐99m/gallium‐67 scintigraphic evaluation of subclinical osteomyelitis complicating fracture nonunion (1985) (25)
Diffuse FDG uptake in the lungs in aspiration pneumonia on positron emission tomographic imaging. (2004) (25)
The receiver operating characteristic curve for the standard uptake value in a group of patients with bone marrow metastasis. (2002) (25)
Changes in the central nervous system during long-duration space flight: implications for neuro-imaging. (1998) (25)
Disturbed visual processing contributes to impaired reading in Alzheimer’s disease (2002) (25)
Tumor Thrombus: Ancillary Findings on FDG PET/CT in an Oncologic Population (2014) (25)
Radionuclide imaging of acute pulmonary embolism. (2001) (25)
in Alzheimer's Dementia and Normal Aging Comparison of CT, MR, and PET (2006) (25)
A brief overview of novel approaches to FDG PET imaging and quantification (2014) (25)
Imaging the islet graft by positron emission tomography (2012) (25)
Beta-Cell Imaging: Call for Evidence-Based and Scientific Approach (2013) (25)
A case of "false-positive" high probability ventilation-perfusion lung scan due to tuberculous mediastinal adenopathy with a discussion of other causes of "false-positive" high probability ventilation-perfusion lung scans. (1991) (24)
Imaging with (18)F-FDG-PET in infective endocarditis: promising role in difficult diagnosis and treatment monitoring. (2009) (24)
The Effect of Age, Menopausal State, and Breast Density on 18F-FDG Uptake in Normal Glandular Breast Tissue (2010) (24)
Assessment of the diagnostic performance of (18)F-FDG-PET/CT for detection and characterization of solid renal malignancies. (2013) (24)
99mTc-MDP uptake in nonosseous lesions. (1980) (24)
The role of dual and multiple time point imaging of FDG uptake in both normal and disease states (2014) (24)
Inter-modality comparisons of seizure focus lateralization in complex partial seizures (2001) (24)
Apical perfusion fraction as a predictor of short-term functional outcome following bilateral lung volume reduction surgery. (2001) (24)
Revolutionary impact of lymphoscintigraphy and intraoperative sentinel node mapping in the clinical practice of oncology. (2001) (24)
High-intensity signals in Alzheimer's disease without cerebrovascular risk factors: a magnetic resonance imaging evaluation. (1992) (24)
Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibody. (1997) (24)
PET and PET/CT: A Clinical Guide (2005) (24)
In vivo quantification of pulmonary inflammation in relation to emphysema severity via partial volume corrected (18)F-FDG-PET using computer-assisted analysis of diagnostic chest CT. (2013) (23)
Quantitative Techniques in PET-CT Imaging (2011) (23)
Reflux esophagitis secondary to chemotherapy detected by serial FDG-PET. (2005) (23)
Diagnostic role of 18 F-FDG pet in gastric malt lymphoma (2006) (23)
Radionuclide imaging of acute pulmonary embolism. (2003) (23)
Detection of age-related changes in thoracic structure and function by computed tomography, magnetic resonance imaging, and positron emission tomography. (2007) (23)
Efficacy of FDG PET/CT Imaging for Venous Thromboembolic Disorders: Preliminary Results From a Prospective, Observational Pilot Study (2015) (23)
Achilles tendonitis detected by FDG-PET. (2006) (23)
Imaging of lymph node uptake after intravenous administration of indium-111 metalloporphyrins. (1986) (23)
Antifibrin scintigraphy in the diagnostic evaluation of acute deep venous thrombosis. (1991) (23)
Gamma camera scintigraphy for direct visualization of larval migration in Strongyloides stercoralis-infected dogs. (1995) (23)
Osteoid osteoma: the role of radionuclide bone imaging, conventional radiography and computed tomography in its management. (1992) (22)
Evolving Role of PET in Detecting and Characterizing Atherosclerosis. (2019) (22)
Quantifying [18F]fluorodeoxyglucose uptake in the arterial wall: the effects of dual time-point imaging and partial volume effect correction (2015) (22)
Intense F-18 fluorodeoxyglucose uptake caused by mycobacterium avium intracellulare infection. (2001) (22)
Hepatic hemangiomas: Pitfalls in scintigraphic detection (1978) (22)
PET and PET-CT imaging in infection and inflammation: its critical role in assessing complications related to therapeutic interventions in patients with cancer. (2010) (22)
Clinical validation of fully 3-D versus 2.5-D RAMLA reconstruction on the Philips-ADAC CPET PET scanner (2004) (22)
Progressive Peripheral Agraphia (2001) (22)
Thallium-201 uptake in lung cancer. (1995) (22)
Increased Tc-99m MDP accumulation in soft tissue caused by bicycle riding. (2004) (22)
The Potential Role of Total Body PET Imaging in Assessment of Atherosclerosis. (2019) (22)
Novel Quantitative PET Techniques for Clinical Decision Support in Oncology. (2018) (22)
18F-sodium fluoride PET/CT provides prognostic clarity compared to calcium and Framingham risk scoring when addressing whole-heart arterial calcification (2019) (22)
Comparison of diagnostic performance with ventilation-perfusion lung imaging in different patient populations. (1996) (22)
Detection of bone marrow metastases by FDG-PET and missed by bone scintigraphy in widespread melanoma. (2005) (22)
Adverse Functional Effects of Chemotherapy on Whole-Brain Metabolism: A PET/CT Quantitative Analysis of FDG Metabolic Pattern of the “Chemo-Brain” (2014) (22)
Improved uniformity in tomographic myocardial perfusion imaging with attenuation correction and enhanced acquisition and processing. (2000) (22)
Quantification of aging effects upon global knee inflammation by 18F-FDG-PET (2015) (22)
Defining co-related parameters between ‘metabolic’ flare and ‘clinical’, ‘biochemical’, and ‘osteoblastic’ flare and establishing guidelines for assessing response to treatment in cancer (2007) (22)
The role of positron emission tomography-computed tomography/magnetic resonance imaging in the management of sarcoidosis patients. (2014) (21)
Radiosynthesis of 1-(4-(2-[18F]fluoroethoxy)benzenesulfonyl)-3-butyl urea: a potential β-cell imaging agent (2002) (21)
Spontaneous Regression of Follicular, Mantle Cell, and Diffuse Large B-Cell Non-Hodgkin's Lymphomas Detected by FDG–PET Imaging (2004) (21)
Simulating technetium-99m cerebral perfusion studies with a three-dimensional Hoffman brain phantom: Collimator and filter selection in SPECT neuroimaging (1996) (21)
Use of positron emission tomography and evoked potentials in the detection of cortical afferents from the gastrointestinal tract. (1996) (21)
Chest tube insertion as a potential source of false-positive FDG-positron emission tomographic results. (2002) (21)
LOCAL CEREBRAL BLOOD VOLUME IN HEAD-INJURED PATIENTS. DETERMINATION BY EMISSION COMPUTED TOMOGRAPHY OF 99mTc-LABELED RED CELLS (1980) (21)
Cerebral glucose consumption following verbal auditory stimulation (1987) (21)
PET in seizure disorders. (2005) (21)
Effects of age and cardiovascular risk factors on (18)F-FDG PET/CT quantification of atherosclerosis in the aorta and peripheral arteries. (2015) (21)
Assessing the feasibility of NaF-PET/CT versus FDG-PET/CT to detect abdominal aortic calcification or inflammation in rheumatoid arthritis patients (2020) (21)
PET-Based Thoracic Radiation Oncology. (2016) (21)
18F-FDG PET in Detecting Primary Breast Cancer (2007) (20)
Assessment of Global Cardiac Uptake of Radiolabeled Iron Oxide Nanoparticles in Apolipoprotein-E-Deficient Mice: Implications for Imaging Cardiovascular Inflammation (2013) (20)
Detection of choriocarcinoma in the lung by FDG positron emission tomography. (2001) (20)
Technetium-99m pertechnetate salivary gland imaging: its role in the diagnosis of Warthin's tumor. (1994) (20)
Regression of pulmonary MALT lymphoma after treatment with rituximab (2005) (20)
Percutaneous ethanol ablation of an adrenal tumor. (2000) (20)
Potential of PET/CT in assessing dementias with emphasis on cerebrovascular disorders (2020) (20)
Overview of Positron Emission Tomography, Hybrid Positron Emission Tomography Instrumentation, and Positron Emission Tomography Quantification (2013) (20)
Evolving role of FDG PET imaging in assessing joint disorders: a systematic review (2011) (20)
Effects of aging on the cerebral distribution of technetium-99m hexamethylpropylene amine oxime in healthy humans (1997) (20)
Association between age, uptake of 18F-fluorodeoxyglucose and of 18F-sodium fluoride, as cardiovascular risk factors in the abdominal aorta. (2019) (20)
Multimodality detection of multicentric breast cancer (2005) (20)
Morphine‐augmented hepatobiliary scintigraphy: A meta‐analysis (1995) (20)
Positron emission tomography in cerebrovascular disorders. (1992) (20)
Middle cerebral artery strokes causing homonymous hemianopia: Positron emission tomography (1990) (20)
Visual Processing Impairments and Decrements in Regional Brain Activity in Alzheimer’s Disease (2004) (20)
Quantitative evaluation of normal spinal osseous metabolism with 18F-NaF PET/CT (2018) (20)
Characterization of Radioiodinated TISCH: A High‐Affinity and Selective Ligand for Mapping CNS D1 Dopamine Receptor (1992) (20)
Varicella Zoster Infection Associated Rhabdomyolysis Demonstrated by Tc‐99m MDP Imaging (2003) (19)
Pulmonary Lymphangitic Carcinomatosis (PLC): Spectrum of FDG-PET Findings (2006) (19)
Age-related decrease in cardiopulmonary adrenergic neuronal function in children as assessed by I-123 metaiodobenzylguanidine imaging (2008) (19)
A critical review of radiotracers in the positron emission tomography imaging of traumatic brain injury: FDG, tau, and amyloid imaging in mild traumatic brain injury and chronic traumatic encephalopathy (2020) (19)
Single photon emission computed tomography in Alzheimer's disease and related disorders. (1995) (19)
Does 2-FDG PET Accurately Reflect Quantitative In Vivo Glucose Utilization? (2019) (19)
Imaging Atherosclerosis by PET, With Emphasis on the Role of FDG and NaF as Potential Biomarkers for This Disorder (2020) (19)
Etiopathologies Associated with Intercostal Muscle Hypermetabolism and Prominent Right Ventricle Visualization on 2-Deoxy-2[F-18]fluoro-d-glucose-Positron Emission Tomography: Significance of an Incidental Finding and in the Setting of a Known Pulmonary Disease (2007) (19)
Role of 18F-NaF-PET in assessing aortic valve calcification with age. (2020) (19)
A prospective study of the feasibility of FDG-PET/CT imaging to quantify radiation-induced lung inflammation in locally advanced non-small cell lung cancer patients receiving proton or photon radiotherapy (2018) (19)
Nononcological Applications of Positron Emission Tomography for Evaluation of the Thorax (2013) (18)
Staging with PET and the “Will Rogers” effect: redefining prognosis and survival in patients with cancer (2007) (18)
Evaluation of diagnostic performance of 18F-FDG-PET compared to CT in detecting potential causes of fever of unknown origin in an academic centre. (2011) (18)
Feasibility and performance of an adaptive contrast-oriented FDG PET/CT quantification technique for global disease assessment of malignant pleural mesothelioma and a brief review of the literature. (2015) (18)
What Can Be and What Cannot Be Accomplished With PET: Rectifying Ongoing Misconceptions (2017) (18)
PET imaging in neuroendocrine tumors: current status and future prospects. (2008) (18)
18F-FDG-PET/CT in the quantification of photon radiation therapy-induced vasculitis. (2020) (18)
Detection of endoleaks after endovascular aneurysm repair with use of technetium-99m sulfur colloid and (99m)Tc-labeled red blood cell scans. (2006) (18)
FDG-PET/CT of COVID-19 and Other Lung Infections (2021) (18)
Value of 18F-FDG PET versus iliac biopsy in the initial evaluation of bone marrow infiltration in the case of Hodgkin’s disease: a meta-analysis (2013) (18)
Positron emission tomography in psychiatric disorders (2011) (18)
Automatic anatomy recognition via multiobject oriented active shape models. (2010) (18)
Quantitative assessment of global hepatic glycolysis in patients with cirrhosis and normal controls using 18F-FDG-PET/CT: a pilot study (2013) (18)
Nuclear imaging of solid hepatic masses. (1995) (18)
A pilot study of changes in (18)F-FDG uptake, calcification and global metabolic activity of the aorta with aging. (2009) (18)
Nuclear Medicine Technology (2002) (18)
Realities of diagnosing Helicobacter pylori infection in clinical practice: a case for non-invasive indirect methodologies. (1998) (17)
Hyperpolarized helium-3 MR imaging of pulmonary function. (2005) (17)
Suboptimal and inadequate quantification: an alarming crisis in medical applications of PET (2011) (17)
Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging. (2007) (17)
Conventional and functional imaging in the evaluation of temporomandibular joint rheumatoid arthritis: a systematic review. (2019) (17)
Copper Loading of Preformed Nanoparticles for PET-Imaging Applications. (2017) (17)
Potential role of FDG PET/CT imaging for assessing venous thromboembolic disorders. (2012) (17)
FDG PET imaging for diagnosing prosthetic joint infection: discussing the facts, rectifying the unsupported claims and call for evidence-based and scientific approach (2013) (17)
PET and PET/CT for unknown primary tumors. (2011) (17)
Circular Inference in Dementia Diagnostics. (2018) (17)
Diagnostic role of 18F-FDG PET in gastric MALT lymphoma. (2006) (17)
A noninvasive strategy for the management of patients suspected of pulmonary embolism. (1991) (17)
Defining the role of modern imaging techniques in assessing lymph nodes for metastasis in cancer: evolving contribution of PET in this setting (2011) (17)
Radiologic diagnosis of brain death. (2002) (17)
Fluorodeoxyglucose-positron-emission tomography findings in mantle cell lymphoma. (2011) (17)
NMR imaging of the abdomen at 0.12 T: initial clinical experience with a resistive magnet. (1983) (17)
18F-Sodium Fluoride PET as a Diagnostic Modality for Metabolic, Autoimmune, and Osteogenic Bone Disorders: Cellular Mechanisms and Clinical Applications (2021) (17)
Role of Imaging in Prostate Cancer. (2009) (17)
Assessment of regional blood flow in cerebral motor and sensory areas in patients with spinal cord injury (2006) (17)
Novel assessment of global metabolism by 18F-FDG-PET for localizing affected lobe in temporal lobe epilepsy (2016) (17)
N-(n-Benzylpiperidin-4-yl)-2-[18F]fluorobenzamide: a potential ligand for PET imaging of breast cancer. (2000) (17)
Futility of attempts to detect and quantify beta cells by PET imaging in the pancreas: why it is time to abandon the approach (2018) (16)
PET-based imaging to detect and characterize cardiovascular disorders: Unavoidable path for the foreseeable future (2018) (16)
Hemodynamic indices of myocardial dysfunction correlate with dipyridamole thallium-201 SPECT. (1996) (16)
Semiquantitative I‐123 IMP spect studies in late onset depression before and after treatment (1991) (16)
Reinventing Molecular Imaging with Total-Body PET, Part I: Technical Revolution in Evolution. (2020) (16)
18F-sodium fluoride: An emerging tracer to assess active vascular microcalcification (2020) (16)
Intraperitoneal urine leak following renal transplant: the role of radionuclide imaging. (1990) (16)
Infectious imaging with indium-111-labeled nonspecific polyclonal human immunoglobulin. (1991) (16)
PET-Based Personalized Management of Infectious and Inflammatory Disorders. (2016) (16)
18F-FDG uptake and breast density in women with normal breast tissue. (2004) (16)
Radionuclide studies of the upper gastrointestinal tract in children with feeding disorders. (1995) (16)
Deep venous thrombosis on F-18 FDG PET/CT imaging. (2006) (16)
Diagnosis and Monitoring of Osteoporosis With 18F-Sodium Fluoride PET: An Unavoidable Path for the Foreseeable Future. (2018) (16)
Metabolic consequences of acute brain trauma: is there a role for PET? (1996) (16)
Beta-cell Imaging: Opportunities and Limitations (2011) (16)
Serial Changes of FDG Uptake and Diagnosis of Suspected Lung Malignancy: A Lesion-Based Analysis (2013) (16)
Detection of Small Bowel Involvement by Mantle Cell Lymphoma on F-18 FDG Positron Emission Tomography (2002) (16)
Applications of PET Imaging in the Evaluation of Musculoskeletal Diseases Among the Geriatric Population. (2018) (16)
CT-based tissue segmentation to assess knee joint inflammation and reactive bone formation assessed by 18F-FDG and 18F-NaF PET/CT: Effects of age and BMI. (2018) (16)
Increased 18F-FDG uptake suggests synovial inflammatory reaction with osteoarthritis: preliminary in-vivo results in humans (2015) (16)
False-Negative and False-Positive Results in FDG-PET and PET/CT in Breast Cancer. (2009) (16)
Resolving metabolic abnormalities in a case of pure alexia (1988) (16)
Staging and monitoring response to treatment in primary non-Hodgkin's lymphoma of bone marrow using (18)F-fluorodeoxyglucose positron emission tomography. (2001) (15)
Regional cerebral glucose metabolism in aphemia: A case report (1987) (15)
An update on the unparalleled impact of FDG-PET imaging on the day-to-day practice of medicine with emphasis on management of infectious/inflammatory disorders (2019) (15)
Quantitative thoracic aorta calcification assessment by 18F-NaF PET/CT and its correlation with atherosclerotic cardiovascular disorders and increasing age (2020) (15)
Association of triglyceride to high density lipoprotein ratio with global cardiac microcalcification to evaluate subclinical coronary atherosclerosis in non-diabetic individuals. (2020) (15)
Nononcologic Applications of PET/CT and PET/MRI in Musculoskeletal, Orthopedic, and Rheumatologic Imaging: General Considerations, Techniques, and Radiopharmaceuticals (2017) (15)
The Clinical Utility of the Tc-99m SC Intraperitoneal Scan in CAPD Patients (1989) (15)
Biodistribution and dosimetry of iodine-123-IBF: a potent radioligand for imaging the D2 dopamine receptor. (1993) (15)
PET/Computed Tomography Evaluation of Infection of the Heart. (2019) (15)
Reinventing Molecular Imaging with Total-Body PET, Part II (2020) (15)
FIAU : Human dosimetry and infection imaging in patients with suspected prosthetic joint infection (2017) (15)
Scintigraphic diagnosis of a right to left shunt in end-stage lung disease. (2003) (15)
FDG-PET imaging to detect and characterize underlying causes of fever of unknown origin: an unavoidable path for the foreseeable future (2018) (15)
Tumor metabolism measured by partial volume corrected standardized uptake value varies considerably in primary and metastatic sites in patients with lung cancer. A new observation. (2009) (15)
PET and PET/CT (2013) (15)
Photo essay. MRI and positron emission tomography findings in Heidenhain variant Creutzfeldt-Jakob disease. (2010) (14)
Evaluation of Musculoskeletal Disorders with PET, PET/CT, and PET/MR Imaging. (2008) (14)
Unparalleled and revolutionary impact of PET imaging on research and day to day practice of medicine (2021) (14)
Induced renal artery stenosis in rabbits: magnetic resonance imaging, angiography, and radionuclide determination of blood volume and blood flow. (1988) (14)
Emerging role of 18F-FDG PET/CT in Castleman disease: a review (2021) (14)
Intracranial myeloid metaplasia: Diagnosis by CT and Fe52 scans and treatment by cranial irradiation (1983) (14)
Synthesis and in vitro Evaluation of (S)‐2‐([11C]Methoxy)‐4‐ [3‐methyl‐1‐(2‐piperidine‐1‐yl‐phenyl)‐butyl‐carbamoyl]‐benzoic Acid ([11C]Methoxy‐repaglinide): A Potential β‐Cell Imaging Agent. (2005) (14)
Diagnosis of non-osseous spinal metastatic disease: the role of PET/CT and PET/MRI (2018) (14)
Impact of fluorodeoxyglucose PET on the management of esophageal cancer (2009) (14)
Extended staging of oesophageal cancer using FDG-PET - a critical appraisal. (2012) (14)
Mild-to-moderate hyperglycemia will not decrease the sensitivity of 18F-FDG PET imaging in the detection of pedal osteomyelitis in diabetic patients (2015) (14)
Scintigraphic examination of bone and marrow infarcts in sickle cell disorders. (1987) (14)
Significance of early tubular extraction in the first minute of Tc-99m MAG3 renal transplant scintigraphy. (1998) (14)
FDG-PET is useful in staging and follow-up of primary uterine cervical lymphoma. (2007) (14)
A pilot study to assess the utility of SPECT/CT-based lymph node imaging to localize lymph nodes that drain the arm in patients undergoing treatment for breast cancer (2009) (14)
Comparison of methods of quantifying global synovial metabolic activity with FDG‐PET/CT in rheumatoid arthritis (2019) (14)
The 'mouse face' appearance of the vertebrae in Paget's disease. (1997) (14)
Potential Roles of Total-Body PET/Computed Tomography in Pediatric Imaging. (2020) (14)
The SNM Practice Guideline for Therapy of Thyroid Disease with 131 I 3.0* (2011) (14)
FDG PET and PET/CT in the Management of Pediatric Lymphoma Patients. (2008) (14)
Multimodality optical imaging and 18F-FDG uptake in wild-type p53-containing and p53-null human colon tumor xenografts (2007) (14)
Similar Pelvic Abnormalities on FDG Positron Emission Tomography of Different Origins (2001) (14)
Synthesis of fluorine‐18 labeled sulfonureas as β‐cell imaging agents (2001) (14)
PET and PET/CT: A Clinical Guide, 2nd ed. (2009) (14)
Normal patterns of regional brain 18F-FDG uptake in normal aging. (2018) (14)
Bone marrow scan evaluation of arthropathy in sickle cell disorders. (1976) (14)
Functional imaging of the interaction between gut microbiota and the human host: A proof-of-concept clinical study evaluating novel use for 18F-FDG PET-CT (2018) (14)
Evolving Importance of Diffusion-Weighted Magnetic Resonance Imaging in Lymphoma. (2012) (14)
PET in cardiology. (2005) (14)
Radioimmunodetection of human tumor xenografts by monoclonal antibody F(ab')2 fragments. (1986) (14)
Incidental detection of an abdominal aortic aneurysm during evaluation of gastrointestinal bleeding with Tc-99m-tagged erythrocytes. (2002) (14)
Malignant lesions can mimic gastric uptake on FDG PET. (2006) (13)
Assessment of Total-Body Atherosclerosis by PET/Computed Tomography. (2020) (13)
Changes in cerebral blood flow associated with premenstrual syndrome: A preliminary study (2000) (13)
Effects of a 99mTc-labeled murine immunoglobulin M antibody to CD15 antigens on human granulocyte membranes in healthy volunteers. (1999) (13)
The role of 18F-FDG-PET/CT in the Diagnosis of left-sided Endocarditis: native vs. prosthetic valves endocarditis. (2019) (13)
Small urine leak after renal transplantation: detection by delayed 99mTc-DTPA renography--a case report. (2005) (13)
Metastatic Seeding Attacks Bone Marrow, Not Bone: Rectifying Ongoing Misconceptions. (2019) (13)
FDG Positron Emission Tomography in Isolated Limb Perfusion Therapy in Patients with Locally Advanced Melanoma: Preliminary Results (2001) (13)
Applications of gallium-67 scintigraphy in the management of patients with malignant lymphoma. (1991) (13)
The effect of metal artefact reduction on CT-based attenuation correction for PET imaging in the vicinity of metallic hip implants: a phantom study (2014) (13)
Feasibility of estimation of brain volume and 2-deoxy-2-(18)F-fluoro-D-glucose metabolism using a novel automated image analysis method: application in Alzheimer's disease. (2012) (13)
PET/MRI depicts the exact location of meniscal tear associated with synovitis (2006) (13)
Assessment of Physiologic Intracranial Calcification in Healthy Adults Using 18F-NaF PET/CT (2018) (13)
Transiently increased MDP activity in the soft tissue of lower extremity caused by iliofemoral venous thrombosis. (2005) (13)
The Detection of Uterine Leiomyoma (Fibroid) Calcifications on 18F-NaF PET/CT. (2018) (13)
Oncological Applications of Positron Emission Tomography for Evaluation of the Thorax (2013) (13)
Normal patterns and variants in single-photon emission computed tomography and positron emission tomography brain imaging. (2003) (13)
Positron emission tomography (PET): a new tool in the diagnosis of endocarditis. (2009) (13)
Use of Radiotracer for Sentinel Lymph Node Mapping in Breast Cancer Optimizes Staging Independent of Site of Administration (2006) (13)
Revolutionary impact of PET and PET-CT on the day-to-day practice of medicine and its great potential for improving future health care. (2009) (13)
A novel method to assess subchondral bone formation using [18F]NaF-PET in the evaluation of knee degeneration (2018) (13)
Age-related structural and functional changes in the breast: multimodality correlation with digital mammography, computed tomography, magnetic resonance imaging, and positron emission tomography. (2007) (13)
Optimizing interventions for preventing uptake in the brown adipose tissue in FDG-PET (2008) (13)
Atherosclerosis Imaging with 18F-Sodium Fluoride PET (2020) (13)
Cold Defects in ln-111 Labeled Leukocyte Imaging of Osteomyelitis in the Axial Skeleton (1991) (13)
Effect of diazepam on the efficacy of dual-phase FDG PET imaging (2006) (12)
Detection of Barrett's esophagus superimposed by esophageal cancer by FDG positron emission tomography. (2001) (12)
Prognostic Implications of Total Hemispheric Glucose Metabolism Ratio in Cerebrocerebellar Diaschisis (2017) (12)
18F-Fluorodeoxyglucose positron emission tomography and infectious diseases: current applications and future perspectives (2017) (12)
18F-FDG uptake and clearance in patients with compromised renal function (2016) (12)
What are the sources of error in measuring and calculating cerebral metabolic rates with fluorine-18-fluorodeoxyglucose and PET? (1994) (12)
Neuro-imaging and positron emission tomography of congenital homonymous hemianopsia. (1991) (12)
Antigranulocyte scintigraphy in infected hip prosthesis: the diagnostic importance of delayed 20–24-h imaging and semiquantitative analysis (2008) (12)
Advantages and Applications of Total-Body PET Scanning (2022) (12)
Complex partial epilepsy: the role of neuroimaging in localizing a seizure focus for surgical intervention. (1990) (12)
Historic images in nuclear medicine: 1976: the first issue of clinical nuclear medicine and the first human FDG study. (2014) (12)
Diagnostic Role of Fluorodeoxyglucose PET in Breast Cancer: A History to Current Application. (2018) (12)
Sequential computerized tomography and positron emission tomography studies in a patient with malignant glioma. (1987) (12)
METABOLIC MAPPING OF FUNCTIONAL CEREBRAL ACTIVITY IN MAN USING THE 18F-2-FLUORO-2-DEOXYGLUCOSE TECHNIQUE (1978) (12)
A Metabolic Imaging Severity Rating Scale for the Assessment of Cognitive Impairment (2003) (12)
A patient with medullary thyroid carcinoma and right ventricular cardiac metastasis treated by (90)Y-Dotatoc. (2009) (12)
A case of microgastria in association with splenic-gonadal fusion (2006) (12)
Evolving Roles of Fluorodeoxyglucose and Sodium Fluoride in Assessment of Multiple Myeloma Patients: Introducing a Novel Method of PET Quantification to Overcome Shortcomings of the Existing Approaches. (2019) (12)
Non-Hodgkin's lymphoma of the bone can mimic osteomyelitis on FDG PET. (2007) (12)
On the use of [18F]DOPA as an imaging biomarker for transplanted islet mass (2013) (12)
The role of PET/CT as a prognosticator and outcome predictor in lung cancer (2016) (12)
Positron emission tomography in a patient with progressive multifocal leukoencephalopathy (1988) (12)
Physiologic colonic fluorine-18-fluorodeoxyglucose uptake may predict response to immunotherapy in patients with metastatic melanoma (2019) (12)
Applications of global quantitative18F-FDG-PET analysis in temporal lobe epilepsy (2015) (12)
Role of radionuclide imaging in patients with suspected pulmonary embolism. (1993) (12)
FDG PET and PET/CT Imaging in Complicated Diabetic Foot. (2012) (12)
Relation between popliteal-tibial artery atherosclerosis and global glycolytic metabolism in the affected diabetic foot: a pilot study using quantitative FDG-PET. (2012) (11)
Acute Renal Allograft Rejection: Difficulty in Diagnosis of Histologically Mild Cases by MR Imaging (1987) (11)
Cold Lesions on Bone Scan in Pediatric Neoplasms (1984) (11)
Functional oncoimaging techniques with potential clinical applications. (2012) (11)
Determination of local cerebral glucose metabolism in humans: methodology and applications to the study of sensory and cognitive stimuli. (1985) (11)
Neuromolecular Imaging Instrumentation Demonstrating DysfunctionalBrain Function in Schizophrenic Patients (2013) (11)
Role of FDG-PET/CT in Assessing the Correlation Between Blood Pressure and Myocardial Metabolic Uptake (2020) (11)
Suboptimal validity of amyloid imaging-based diagnosis and management of Alzheimer’s disease: why it is time to abandon the approach (2019) (11)
The study of neurological disorders using positron emission tomography and single photon emission computed tomography (1996) (11)
PET/MR Imaging: Clinical Applications. (2016) (11)
Competitive speed eating: truth and consequences. (2007) (11)
Pulmonary clostridium perfringens infection detected by FDG positron emission tomography. (2003) (11)
Clinical Significance of Incidental Focal Versus Diffuse Thyroid Uptake on FDG-PET Imaging. (2007) (11)
FDG-PET imaging to detect and characterize infectious disorders; an unavoidable path for the foreseeable future (2017) (11)
Use of lymphoscintigraphy in radiation treatment of primary breast cancer in the context of lymphedema risk reduction. (2011) (11)
Applications of Fluorodeoxyglucose PET/Computed Tomography in the Assessment and Prediction of Radiation Therapy-related Complications. (2015) (11)
99mTc-phytate as a diagnostic probe for assessing inflammatory reaction in malignant tumors (2015) (11)
PET and Parathyroid. (2007) (11)
Evaluation of Infection in Neutropenic Patients with lndium-111-Labeled Donor Granulocytes (1980) (11)
Positron emission tomography in seizure disorders (2011) (11)
PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma (2018) (11)
FDG-PET in the clinical management of carcinoma of unknown primary with metastatic cervical lymphadenopathy: shifting gears from detecting the primary to planning therapeutic strategies (2007) (11)
The role of modern molecular imaging techniques in gastroenterology. (2008) (11)
F-18 FDG positron emission tomography to differentiate diabetic osteoarthropathy from septic arthritis. (2001) (11)
Hepatobiliary scintigraphy: morphine-augmented versus delayed imaging in patients with suspected acute cholecystitis. (1993) (11)
NaF-PET/CT global assessment in detecting and quantifying subclinical cardiac atherosclerosis and its association with blood pressure in non-dyslipidemic individuals. (2020) (10)
Role of (18)F-fluorodeoxyglucose positron emission tomography imaging in the management of primary cutaneous lymphomas. (2014) (10)
Evolving Role of PET-Based Novel Quantitative Techniques in the Management of Hematological Malignancies. (2019) (10)
Pleuroperitoneal Communication in a Patient with Right Pleural Effusion and Ascites Diagnosed by Technetium-99m Sulfur Colloid Imaging (1988) (10)
Atherosclerotic inflammatory activity in the aorta and its correlation with aging and gender as assessed by 18F-FDG-PET. (2013) (10)
Localization of Pheochromocytoma: MIGB, CT, and MRI Correlation (2006) (10)
Cerebral ischemia and Alzheimer's disease: critical role of PET and implications for therapeutic intervention. (1998) (10)
(18)F-FDG-PET/CT findings in patients affected by spondylodiscitis. (2010) (10)
Alavi–Carlsen Calcification Score (ACCS): A Simple Measure of Global Cardiac Atherosclerosis Burden (2021) (10)
Reduced grey matter metabolism due to white matter edema allows optimal assessment of brain tumors on 18F-FDG-PET. (2011) (10)
Use of Iodine 131I-Tositumomab Radioimmunotherapy in a Patient with Waldenstrom's Macroglobulinemia (2004) (10)
Identification of Heterotopic Ossification Using 18F-NaF PET/CT. (2019) (10)
Debate on human aging and lifespan (2017) (10)
Evolving Role of PET/CT-MRI in Assessing Muscle Disorders. (2019) (10)
Contralateral cortical diaschisis in a patient with cerebellar astrocytoma after radiation therapy. (2000) (10)
Multimodality Imaging Approach in Alzheimer disease. Part I: Structural MRI, Functional MRI, Diffusion Tensor Imaging and Magnetization Transfer Imaging (2015) (10)
PET/CT in Neuroendocrine Tumors: Evaluation of Receptor Status and Metabolism. (2008) (10)
Hiatal hernia mimics centrally necrotic cancer in the lung on FDG positron emission tomographic imaging. (2003) (10)
Utility of 18F-FDG-PET/CT imaging in the diagnosis of appendicitis. (2009) (10)
Detection of Cranial Metastases by F-18 FDG Positron Emission Tomography (2001) (10)
Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results (2016) (10)
Critical considerations on the combined use of 18F-FDG and 18F-fluoride for PET assessment of metastatic bone disease (2013) (10)
Incremental value of FDG-PET/CT to monitor treatment response in infectious spondylodiscitis (2020) (10)
Association between atherosclerotic cardiovascular disease risk score estimated by pooled cohort equation and coronary plaque burden as assessed by NaF-PET/CT. (2020) (10)
Automatic anatomy recognition via multi-object-oriented active shape models (2009) (10)
Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer (2018) (10)
Correlation between Quantified Breast Densities from Digital Mammography and 18F‐FDG PET Uptake (2009) (10)
Deep venous thrombosis and pulmonary embolism detected by FDG PET/CT in a patient with bacteremia. (2013) (10)
Superscan-like hypermetabolic lesions on delayed FDG PET/CT imaging in a patient with lung cancer. (2012) (10)
Hodgkin disease in the sinonasal region detected by FDG PET. (2004) (9)
Assessing respitatory muscle activity with 18F-FDG-PET/CT in patients with COPD. (2019) (9)
Identification of Tracheobronchial Tree Calcifications Using Molecular Imaging Probes: 18F-NaF PET/CT. (2018) (9)
A Study of the Feasibility of FDG-PET/CT to Systematically Detect and Quantify Differential Metabolic Effects of Chronic Tobacco Use in Organs of the Whole Body-A Prospective Pilot Study. (2017) (9)
PET, CT, and MR Imaging for Assessment of Thoracic Malignancy: Structure Meets Function. (2008) (9)
Positron emission tomography in chronic obstructive pulmonary disease. (2013) (9)
MRI volumetric studies in Alzheimer's disease: relationship to clinical and neuropsychological variables. (1994) (9)
Detection of unsuspected recurrent lymphoma with fluorodeoxyglucose-positron emission tomographic imaging after induction chemotherapy: a case study. (1998) (9)
Age-related inflammatory changes in the spine as demonstrated by (18)F-FDG-PET:observation and insight into degenerative spinal changes. (2012) (9)
Cerebral Blood Flow Effects of Pain and Acupuncture: A Preliminary Single‐Photon Emission Computed Tomography Imaging Study (2005) (9)
Underestimated Role of 18F-FDG PET for HCC Evaluation and Promise of 18F-FDG PET/MR Imaging in This Setting (2013) (9)
Abnormal Brain Circuitry and Neurophysiology Demonstrated by Molecular Imaging Modalities in Schizophrenia (2014) (9)
The evaluation of the patient with gastroparesis secondary to insulin-dependent diabetes mellitus. (1992) (9)
Evolving Role of MR Imaging and PET in Assessing Osteoporosis. (2019) (9)
Partial volume correction and image segmentation for accurate measurement of standardized uptake value of grey matter in the brain (2015) (9)
Differential washout of FDG activity in two different inflammatory lesions: implications for delayed imaging. (2013) (9)
Insights into the dose-response relationship of hepatic radioembolization with resin yttrium-90 microspheres: a prospective cohort study in patients with colorectal cancer liver metastases (2016) (9)
Normal Patterns and Variants in PET Brain Imaging. (2010) (9)
Evaluating the Role of Fluorodeoxyglucose PET Imaging in the Management of Patients with Sarcoidosis. (2006) (9)
Detection by 18F-FDG-PET/CT of upper extremity acute deep venous thrombosis. (2011) (9)
Significantly elongated sagging gallbladder can mimic intestine in hepatobiliary scintigraphy and cause false-positive interpretation for acute cholecystitis. (2006) (9)
FDG uptake in intercostal muscles is an indicator of severe respiratory disease. (2004) (9)
Metastatic melanoma causing complete atrioventricular block--the role of FDG PET/CT in diagnosis. (2011) (9)
18F-Fluorodeoxyglucose positron emission tomography/computed tomography findings in a patient with human immunodeficiency virus-associated Castleman’s disease and Kaposi sarcoma, disorders associated with human herpes virus 8 infection (2010) (9)
Common carotid artery molecular calcification assessed by 18F-NaF PET/CT is associated with increased cardiovascular disease risk: Results from the CAMONA study (2017) (9)
Utilization of NaF-PET/CT in assessing global cardiovascular calcification using CHADS2 and CHADS2-VASc scoring systems in high risk individuals for cardiovascular disease. (2020) (9)
18F-FDG-PET/CT in measuring volume and global metabolic activity of thigh muscles: a novel CT-based tissue segmentation methodology (2019) (8)
Magnetic Resonance Imaging Hyperintensities in Alzheimer's Disease (1991) (8)
Clinical and positron emission tomography studies of visual apperceptive agnosia (1996) (8)
Effects of age and weight on the metabolic activities of the cervical, thoracic and lumbar spines as measured by fluorine-18 fluorodeoxyglucose-positron emission tomography in healthy males. (2018) (8)
Differential background clearance of fluorodeoxyglucose activity in normal tissues and its clinical significance. (2014) (8)
Stability of cerebral blood flow measures using a split-dose technique with 99mTc-exametazime SPECT (2005) (8)
Comment on: “Tumor Aggressiveness and Patient Outcome in Cancer of the Pancreas Assessed by Dynamic 18F-FDG PET/CT” (2014) (8)
Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody. (2003) (8)
Reference values for fluorine-18-fluorodeoxyglucose and fluorine-18-sodium fluoride uptake in human arteries: a prospective evaluation of 89 healthy adults (2017) (8)
Clinical and Research Applications of Quantitative PET Imaging. (2007) (8)
An Update on the Role of Total-Body PET Imaging in the Evaluation of Atherosclerosis. (2020) (8)
Pre-treatment partial-volume-corrected TLG is the best predictor of overall survival in patients with relapsing/refractory non-hodgkin lymphoma following radioimmunotherapy. (2018) (8)
Detection and Quantification of Molecular Calcification by PET/Computed Tomography: A New Paradigm in Assessing Atherosclerosis. (2011) (8)
Complementary roles of PET and MR spectroscopy in the management of brain tumors. (1990) (8)
PET measurements of cerebral metabolism corrected for CSF contributions (1984) (8)
Comparison of 18F-sodium fluoride uptake in the whole bone, pelvis, and femoral neck of multiple myeloma patients before and after high-dose therapy and conventional-dose chemotherapy (2020) (8)
Regional Variation in Skeletal Muscle and Adipose Tissue FDG Uptake Using PET/CT and Their Relation to BMI. (2017) (8)
The role of nuclear medicine in the evaluation of the male genital tract. (1993) (8)
The aging of the heart and blood vessels: a consideration of anatomy and physiology in the era of computed tomography, magnetic resonance imaging, and positron emission tomographic imaging methods with special consideration of atherogenesis. (2007) (8)
Absence of increased frequency of bone and joint disease with hemoglobin AS and AC. (1977) (8)
64Cu-DOTATOC PET-CT in Patients with Neuroendocrine Tumors (2019) (8)
Risk Stratification of Patients With Apparently Idiopathic Premature Ventricular Contractions (2019) (8)
The Role of Neuroimaging in Assessing Neuropsychological Deficits following Traumatic Brain Injury (2011) (8)
“Global” cardiac atherosclerotic burden assessed by artificial intelligence-based versus manual segmentation in 18F-sodium fluoride PET/CT scans: Head-to-head comparison (2021) (8)
Can semiquantitative measurements of SUVmax and cut-off values differentiate colorectal malignant from benign lessions? (2017) (8)
Global quantification of pulmonary artery atherosclerosis using 18F-sodium fluoride PET/CT in at-risk subjects. (2020) (8)
Patterns of 18F-FDG PET images in patients with uncomplicated total hip arthroplasty. (2015) (7)
The critical role of FDG-PET/CT imaging in assessing systemic manifestations of COVID-19 infection (2021) (7)
Detection of thrombophlebitis with 111In-labeled anti-fibrin antibody: preliminary results. (1990) (7)
Potential Role of PET in Assessing Ventricular Arrhythmias. (2019) (7)
Application of 18F-Fluorodeoxyglucose and PET in Evaluation of the Diabetic Foot. (2006) (7)
Potential clinical role of fluorodeoxyglucose-positron emission tomography in assessing primary or secondary lymphomas of the parotid gland. (2007) (7)
Pelvic kidney mimicking recurrent colon cancer on FDG positron emission tomographic imaging. (2002) (7)
PET imaging of β‐cell mass: is it feasible? (2012) (7)
Prognostic significance of 18F-sodium fluoride in newly diagnosed multiple myeloma patients. (2020) (7)
Comment on: “FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging, version 1.0” (2010) (7)
Accurate diagnosis of acute deep venous thrombosis with technetium 99m antifibrin scintigraphy results of phase iii trial (1991) (7)
Potential and Most Relevant Applications of Total Body PET/CT Imaging. (2022) (7)
Applications of PET/CT in Pediatric Patients with Fever of Unknown Origin. (2008) (7)
F-18 FDG uptake in congestive splenomegaly. (2002) (7)
Incidental inflammatory findings in nerves and in patients with neoplastic diseases evaluated by 18F-FDG-PET/CT. (2009) (7)
The evolving role of structural and functional imaging in assessment of age-related changes in the body. (2007) (7)
β-Cell Mass Imaging with DTBZ Positron Emission Tomography: Is it Possible? (2013) (7)
Imaging in vivo herpes simplex virus thymidine kinase gene transfer and expression in tumors using positron emission tomography. (2000) (7)
Early uncoupling of cerebral blood flow and metabolism after bilateral thalamic infarction. (2004) (7)
Ventilation–Perfusion–Chest Radiograph Match Is Less Likely to Represent Pulmonary Embolism If Perfusion Is Decreased Rather Than Absent (2000) (7)
Novel Musculoskeletal and Orthopedic Applications of 18F-Sodium Fluoride PET. (2021) (7)
Follow-up FDG PET in the Evaluation of Unexplained Focal Activity in the Abdomen (2008) (7)
Radiation dosimetry of a 99mTc-labeled IgM murine antibody to CD15 antigens on human granulocytes. (1999) (7)
Assessing Cutaneous Psoriasis Activity Using FDG-PET: Nonattenuation Corrected Versus Attenuation Corrected PET Images. (2015) (7)
Comparison of efficacy of 2220 MBq versus 3700 MBq I-131 for ablation of thyroid remnant in patients with differentiated thyroid cancer. (2010) (7)
Comparison of atherosclerotic burden in non-lower extremity arteries in patients with and without peripheral artery disease using 18F-NaF-PET/CT imaging. (2020) (7)
Trends in PET quantification: opportunities and challenges (2014) (7)
Potential Approaches for Beta Cell Imaging with PET and SPECT (2004) (7)
Imaging the Infected Heart (2011) (7)
Association between common carotid artery molecular calcification assessed by 18F-NaF PET/CT and biomarkers of vulnerable atheromatous plaques: results from the CAMONA study (2017) (7)
PET-Based Imaging with 18F-FDG and 18F-NaF to Assess Inflammation and Microcalcification in Atherosclerosis and Other Vascular and Thrombotic Disorders (2021) (7)
PET and MR Imaging of Brain Tumors. (2008) (7)
Beware of Mosquitoes: The First Instance of a Mosquito Bite Detected by Fluorodeoxyglucose Positron Emission Tomography (2007) (7)
Aducanumab (Marketed as Aduhelm) Approval Is Likely Based on Misinterpretation of PET Imaging Data. (2021) (7)
Assessment of femoral neck bone metabolism using 18F-sodium fluoride PET/CT imaging. (2020) (7)
PET/CT in Neuroendocrine Tumors: Evaluation of Receptor Status and Metabolism. (2007) (7)
[18F]Fluorodeoxyglucose PET for Interventional Oncology in Liver Malignancy. (2014) (7)
Positron emission tomography: ligand imaging. (2016) (7)
The strong but nonspecific relationship between 18F-FDG uptake in the lower-extremity veins and venous thromboembolism (2015) (7)
Sentinel lymph node biopsy in the management of breast cancer. (2003) (7)
An understanding of the atherosclerotic molecular calcific heterogeneity between coronary, upper limb, abdominal, and lower extremity arteries as assessed by NaF PET/CT. (2021) (7)
FDG-PET/CT assessment of differential chemotherapy effects upon skeletal muscle metabolism in patients with melanoma (2014) (7)
Measurement of Local Cerebral Glucose Metabolism: Application to the Study of Stroke (1983) (7)
Progressive intermediate-grade non-Hodgkin's lymphoma after high-dose therapy and autologous peripheral stem-cell transplantation: changing the natural history with monoclonal antibody therapy. (2000) (7)
Assessment of the role of age and cardiovascular risk factors on 18F-Fluorodeoxyglucose (18F-FDG) and 18F-Sodium Fluoride (NaF) uptake in abdominal aortic artery (2018) (6)
Brain: positron emission tomography tracers beyond [¹⁸F]fluorodeoxyglucose. (2014) (6)
Neuroimaging in Patients with Traumatic Brain Injury (1996) (6)
The Evolving Role of PET-Based Novel Quantitative Techniques in the Interventional Radiology Procedures of the Liver. (2019) (6)
Feasibility and utility of ROVER software for 3D quantitative image analysis of FDG-PET in patients with diffuse large B-cell lymphoma (DLBCL) (2009) (6)
Assessment of atherosclerosis in multiple myeloma and smoldering myeloma patients using 18F- sodium fluoride PET/CT (2021) (6)
Horseshoe kidney on FDG positron emission tomographic imaging is easily confused with malignancy. (2001) (6)
FDG PET Assessment of Osteomyelitis: A Review. (2012) (6)
Ventilation perfusion lung scanning in the evaluation of right-to-left shunting. (1992) (6)
Assessing the effects of body weight on subchondral bone formation with quantitative 18F-sodium fluoride PET (2020) (6)
Identical twins with probable alzheimer’s disease: Behavior, anatomy, and physiology (1988) (6)
Correlation of whole-bone marrow dual-time-point 18F-FDG, as measured by a CT-based method of PET/CT quantification, with response to treatment in newly diagnosed multiple myeloma patients. (2020) (6)
Quantification of global lung inflammation using volumetric 18F-FDG PET/CT parameters in locally advanced non-small-cell lung cancer patients treated with concurrent chemoradiotherapy: a comparison of photon and proton radiation therapy (2019) (6)
Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature review (2017) (6)
Intercostal muscle contraction or rib bone marrow activity?: Look for ancillary clues. (2007) (6)
Value of 18-Fluoro-2-Deoxyglucose PET in the Management of Patients with Fever of Unknown Origin. (2006) (6)
The Ongoing Misperception That Labeled Leukocyte Imaging Is Superior to 18F-FDG PET for Diagnosing Prosthetic Joint Infection (2017) (6)
Gated resting Tl-201 SPECT in the evaluation of myocardial viability. (1996) (6)
American Journal of Nuclear Medicine and Molecular Imaging: Editorial Board (2015) e-Century Publishing Corporation. (2015) (6)
Magnetic resonance imaging and scintigraphic correlation in thyroid disorders. (1990) (6)
Role of FDG PET/CT in investigating the mechanisms underlying atherosclerotic plaque formation and evolution. (2013) (6)
PET and PET/CT in the management of thyroid cancer. (2011) (6)
Hepatic hemangiomas: pitfalls in scintigraphic detection. (1978) (6)
Two-year change in 18F-sodium fluoride uptake in major arteries of healthy subjects and angina pectoris patients (2021) (6)
Amelioration of hypoglycemia with octreotide therapy in metastatic insulinoma with positive octreotide scan. (2011) (6)
Total-Body PET Imaging of Musculoskeletal Disorders. (2021) (6)
Patellar metastasis from lung adenocarcinoma revealed by FDG PET/CT. (2012) (6)
Global temporal lobe asymmetry as a semi-quantitative imaging biomarker for temporal lobe epilepsy lateralization: A machine learning classification study. (2018) (6)
Molecular Imaging of Bacteria in Patients Is an Attractive Fata Morgana, Not a Realistic Option (2018) (5)
Should the nuclear medicine community continue to underestimate the potential of 18F-FDG-PET/CT with present generation scanners for the diagnosis of prosthetic joint infection? (2015) (5)
Correlation of Dual Time Point FDG-PET with Response to Chemotherapy in Multiple Myeloma (2017) (5)
Unilateral diffusely increased muscle uptake of F-18 FDG in a patient with hemiparesis due to stroke. (2011) (5)
Potential Clinical Applications of PET/Magnetic Resonance Imaging. (2013) (5)
Effects of development of host immunity on the biodistribution of xenogeneic MHC non-restricted cytotoxic T cells: implications for adoptive cell therapy of cancer. (1999) (5)
Cognitive Impairment and Dementias. (2018) (5)
Massive thyroid involvement by marginal zone B cell NHL as demonstrated by 18F-FDG-PET/CT. (2009) (5)
MRI and Positron Emission Tomography Findings in Heidenhain Variant Creutzfeldt-Jakob Disease (2010) (5)
Changes in bone marrow FDG uptake in multiple myeloma patients before and after treatment (2018) (5)
Novel PET Radiotracers with Potential Clinical Applications. (2017) (5)
Changes in bone marrow FDG uptake in multiple myeloma patients before and after treatment (2018) (5)
Local cerebral metabolic changes in acute ischemic strokes. (1987) (5)
Plurifocal malignant peripheral nerve sheath tumor demonstrated by 18F-fluorodeoxyglucose positron emission tomography/computed tomography (2009) (5)
PET/MR Imaging in Musculoskeletal Precision Imaging - Third wave after X-Ray and MR. (2020) (5)
Pretreatment volumetric parameters of FDG-PET predict the survival after Yttrium-90 radio-embolization in metastatic liver disease. (2019) (5)
The evaluation of the lumped constant for deoxyglucose and fluorodeoxyglucose in man (1984) (5)
Simultaneous PET/MRI in the Evaluation of Breast and Prostate Cancer Using Combined Na[18F]F and [18F]FDG: a Focus on Skeletal Lesions (2019) (5)
Comparison of atherosclerotic inflammation and calcification in subjects with end stage renal disease (ESRD) on hemodialysis to normal controls utilizing 18F-FDG PET/CT. (2018) (5)
Usefulness of non attenuation corrected 18F-FDG-PET images for optimal assessment of disease activity in patients with lymphoma. (2009) (5)
Metabolic effects of pulmonary obstruction on myocardial functioning: a pilot study using multiple time-point 18F-FDG-PET imaging (2015) (5)
Determination of patterns of regional cerebral glucose metabolism in normal aging and dementia (1985) (5)
Diagnosis and Monitoring of Osteoporosis with Total-Body 18F-Sodium Fluoride-PET/CT. (2020) (5)
FDG-PET/CT for venous thromboembolic disorders: Preliminary results (2013) (5)
Fluorodeoxyglucose positron emission tomography excludes pericardial metastasis by recurrent lung cancer. (2003) (5)
Bone scan evaluation of patellar activity. (1981) (5)
(18)F-fluoride imaging for atherosclerosis. (2012) (5)
The dosimetry of iodine-123-labeled TISCH: a SPECT imaging agent for the D1 dopamine receptor. (1993) (5)
393 A trial to determine the effect of psoriasis treatment (adalimumab, phototherapy, and placebo) on cardiometabolic disease: The vascular inflammation in psoriasis (VIP) trial (2018) (5)
Incidental 18F-NaF Uptake in Drug-Induced Gynecomastia. (2019) (5)
A Critical Review of PET Tracers Used for Brain Tumor Imaging. (2021) (5)
in Alzheimer's Dementia and Normal Aging (2006) (5)
Avid FDG uptake in the right ventricle coupled with enhanced intercostal muscle hypermetabolism in pneumoconiosis. (2007) (5)
Understanding human visual cortex : the role of functional imaging (1995) (5)
18F-NaF PET/CT in Prostatic Calculi. (2018) (5)
Glucose-6-phosphatase Expression–Mediated [18F]FDG Efflux in Murine Inflammation and Cancer Models (2019) (5)
18F-FDG-PET/CT in radiation therapy-induced parotid gland inflammation (2020) (5)
Detection of deep venous thrombosis by indium-111 leukocyte scintigraphy. (1986) (5)
2070 : 18F EF5 PET Imaging With Immunohistochemical Validation in Patients With Brain Lesions (2006) (5)
Carotid artery molecular calcification assessed by [18F]fluoride PET/CT: correlation with cardiovascular and thromboembolic risk factors (2021) (5)
Enhancement of Tumor Contrast on Radioimmunoscans by Using Mixtures of Monoclonal Antibody F(ab’)2 Fragments (1986) (5)
Imaging for the diagnosis of thyroid cancer. (2009) (5)
Metabolic brain imaging correlated with clinical features of brain tumors (1985) (5)
Bone Marrow and NOT Bone Metastases Is What 21st-Century Diagnostic Imaging Must Focus on When Looking for Skeletal Metastases (2017) (5)
Efficacy of 18F-FDG and 18F-NaF PET/CT imaging: A novel semi-quantitative assessment of the effects of age and obesity on hip joint inflammation and bone degeneration. (2018) (5)
Radionuclide angiography in evaluation of chemodectomas of the jugular glomus. (1976) (5)
Venous thromboembolism detected by FDG-PET/CT in cancer patients: a common, yet life-threatening observation. (2021) (5)
Amyloid Hypothesis: The Emperor's New Clothes? (2020) (5)
[18F]fluoropropylsqualamine as an angiogenesis imaging agent (2001) (5)
Unrecognized Renal Transplants as a Potential Source of False-Positive Interpretation of FDG PET (2003) (5)
Detection of pulmonary artery atherosclerosis by FDG-PET/CT: a new observation. (2020) (5)
Postsurgical atypical F-18 fluorodeoxyglucose positron emission tomography uptake. (2009) (5)
Multiple Intraabdominal Soft-Tissue Masses in a Man Awaiting Liver Transplantation: A Case Study and Discussion (2000) (5)
Alteration of normal regional brain FDG uptake in normal aging (2017) (5)
Global Quantitative Techniques for Positron Emission Tomographic Assessment of Disease Activity in Cutaneous T-Cell Lymphoma and Response to Treatment. (2016) (5)
Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation (2019) (5)
Studies of GI bleeding with scintigraphy and the influence of vasopressin. (1981) (5)
Correlative Studies of the Brain with Positron Emission Tomography, Nuclear Magnetic Resonance, and X-Ray Computed Tomography (1985) (5)
Muscarinic blockade inhibits gastric emptying of mixed-nutrient meal: effects of weight and gender. (1999) (5)
3D automatic anatomy recognition based on iterative graph-cut-ASM (2010) (5)
THE "MOUSE" APPEARANCE OF A VERTEBRA IS MORE SUGGESTIVE OF PAGET'S DISEASE THAN METASTASIS EVEN IN PATIENTS WITH CANCER (1996) (5)
Critical review of PET imaging for detection and characterization of the atherosclerotic plaques with emphasis on limitations of FDG-PET compared to NaF-PET in this setting. (2021) (5)
Nuclear medicine procedures in the diagnosis of NET: a historical perspective. (2014) (5)
18F-FDG Versus Non-FDG PET Tracers in Multiple Myeloma. (2022) (4)
Potential Applications of PET/CT/MR Imaging in Inflammatory Diseases: Part I: Musculoskeletal and Gastrointestinal Systems. (2020) (4)
Aged related differences and cardiovascular molecular calcification a 18-NaF PET/CT quantification of vascular calcification in the common carotid artery study (2017) (4)
PET Imaging II (2005) (4)
Synthesis and characterization of magnetically responsive albumin microspheres containing cis‐hydroxyproline for scar inhibition (1991) (4)
PET Assessment of Immune Effects from Interventional Oncology Procedures. (2019) (4)
EFFECT OF RAPID BRAIN DEATH DETERMINATION ON ORGAN DONATION RATES: A PRELIMINARY REPORT (1998) (4)
Massive bilateral adrenal gland metastases from melanoma diagnosed by F18-FDG-PET/CT (2009) (4)
Hottest pixel analysis: Useful value or statistical artifact ? (1999) (4)
Diagnostic manifestations of total hemispheric glucose metabolism ratio in neuronal network diaschisis: diagnostic implications in Alzheimer’s disease and mild cognitive impairment (2019) (4)
PET-Computed Tomography and PET-MR Imaging and Their Applications in the Twenty-First Century. (2019) (4)
The indium white blood cell scan in the evaluation of osteomyelitis. (1990) (4)
Emerging role of FDG-PET for optimal response assessment in infectious diseases and disorders (2011) (4)
Defining a role for thrombolytic therapy in the management of pulmonary embolism. (1995) (4)
Pharmacokinetic Models and Positron Emission Tomography: Studies of Physiologic and Pathophysiologic Conditions (1983) (4)
Diagnosis of bone metastases in breast cancer: Lesion-based sensitivity of dual-time-point FDG-PET/CT compared to low-dose CT and bone scintigraphy (2021) (4)
SCINTIGRAPHIC DETECTION OF BONE AND BONE MARROW IN-FARCTS IN SICKLE CELL DISORDERS (1977) (4)
Aducanumab-Related Amyloid-Related Imaging Abnormalities (2022) (4)
Kinetics of Nanoparticle Radiolabeling of Metalloporphyrin with 64Cu for Positron Emission Tomography (PET) Imaging (2020) (4)
Focal and Remote Dysmetabolism in Stroke (1987) (4)
Economic Sanctions Endanger Nuclear Medicine Services in Iran (2019) (4)
PET imaging I. (2004) (4)
Failed PET Application Attempts in the Past, Can We Avoid Them in the Future? (2016) (4)
Comparison of quantitative magnetic resonance imaging and positron emission tomography between patients with dementia of the alzheimer type and multi-infarct dementia. (1992) (4)
Critical role of PET/CT-based novel quantitative techniques for assessing global disease activity in multiple myeloma and other hematological malignancies: why it is time to abandon reliance on examining focal lesions (2020) (4)
18f-fluorodeoxyglucose method for measuring local cerebral glucose metabolism in man: technique and results. (1981) (4)
Review of Clinical Applications of Fluorodeoxyglucose-PET/Computed Tomography in Pediatric Patients with Lymphoma. (2012) (4)
3 The Role of Glucose and FDG Metabolism in the Interpretation of PET Studies (2019) (4)
Positron Emission Tomography Imaging and Hyperinsulinism. (2007) (4)
Assessing global uptake of 18F-sodium fluoride in the femoral neck: a novel quantitative technique to evaluate changes in bone turnover with age (2017) (4)
Role of PET in the Investigation of Neuropsychiatric Disorders. (2010) (4)
Sacroiliac Joint Asymmetry Regarding Inflammation and Bone Turnover: Assessment by FDG and NaF PET/CT (2019) (4)
The role of 18F-FDG PET in the assessment of a benign hematological disorder: polycythemia. (2019) (4)
GC-ASM: synergistic integration of active shape modeling and graph-cut methods (2009) (4)
Assessment of Therapy Response by Fluorine-18 Fluorodeoxyglucose PET in Infection and Inflammation. (2006) (4)
Assessing the feasibility of NaF or FDG as PET probes to evaluate atherosclerosis in rheumatoid arthritis patients (2019) (4)
Noninvasive diagnosis of cardiac transplant arteriopathy with dipyridamole thallium scintigraphy. (1993) (4)
18F-NaF PET/CT quantification of vascular calcification in the thoracic aorta is associated with increasing age and presence of cardiovascular risk factors (2017) (4)
Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) in the diagnosis of acute osteomyelitis in the diabetic foot (2008) (4)
Promising role of dual time FDG-PET imaging in assessing focal and diffuse bone marrow disorders (2006) (4)
18F-FDG, as a single imaging agent in assessing cancer, shows the ongoing biological phenomena in many domains: do we need additional tracers for clinical purposes? (2016) (4)
Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET (2015) (4)
A PET/CT-Based Strategy Is a Stronger Predictor of Survival Than a Standard Imaging Strategy in Patients with Head and Neck Squamous Cell Carcinoma (2017) (4)
Metabolic activity in the painful knee joint as measured on FDG-PET (2008) (4)
Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET). (2004) (4)
The Utility of FDG-PET/CT for Quantifying Radiation-induced Vasculitis (2019) (4)
Regional Cerebral Distribution of [Tc‐99m] Hexylmethylpropylene Amineoxine in Patients With Progressive Aphasia (2000) (4)
Should FDG-PET imaging be considered on a routine basis in clinical trials for carcinoma of esophagus to assure uniformity of protocols among sites? (2007) (4)
Visualization of five hyperplastic parathyroid glands using 99mTc-sestamibi scintigraphy in a patient with chronic renal failure (2007) (4)
N-(N-benzylpiperidin-4-yl)-2-[18F]fluorobenzamide: a potential ligand for PET imaging of sigma receptors. (1997) (4)
PET Imaging of Infection and Inflammation. (2012) (4)
Positron Emission Tomography and Thyroid Cancer. (2007) (3)
Atherosclerotic 18F-FDG and MDP uptake in femoral arteries, changes with age (2016) (3)
Utility of 18 F-FDG PET/CT in pre-surgical risk stratification of patients with breast cancer. (2019) (3)
Applications of FDG-PET/CT in Assessment of Vascular Infection and Inflammation (2014) (3)
Fluorine-18 DOPA-PET and PET/CT Imaging in Congenital Hyperinsulinism. (2008) (3)
16 Breast Cancer (2009) (3)
6 Normal Variants and Benign Findings (2009) (3)
Assessment of Therapy Response by FDG PET in Infection and Inflammation. (2012) (3)
A Dedicated Breast Positron Emission Tomography Scanner: Proof of Concept. (2014) (3)
RETRACTED ARTICLE: Neuroradiological advances detect abnormal neuroanatomy underlying neuropsychological impairments: the power of PET imaging (2013) (3)
A Comparison of Neuroimaging Modalities for Diagnosing Dementia (1995) (3)
Suboptimal Sensitivity and Specificity of PET and Other Gross Imaging Techniques in Assessing Lymph Node Metastasis (2019) (3)
Hours in Patients with Differentiated Thyroid Cancer (2002) (3)
Retraction Note: Neuroradiological advances detect abnormal neuroanatomy underlying neuropsychological impairments: the power of PET imaging (2013) (3)
Positron emission tomography in neurological and psychiatric disorders (2012) (3)
Linked Hexokinase and Glucose-6-Phosphatase Activities Reflect Grade of Ovarian Malignancy (2018) (3)
Central photopenic lesions on FDG-PET scan in a patient with peripheral T cell lymphoma (2008) (3)
Clinical Applications of Positron Emission Tomography in the Evaluation of Spine and Joint Disorders. (2019) (3)
Utility of salivary scintigraphy to monitor treatment of Sjogren's syndrome (SS) using rituximab (2008) (3)
Scintigraphic evaluation of the hyoid bone and the thyroid--cricoid cartilage. (1981) (3)
Venous thromboembolism detected by FDG PET/CT in cancer patients: A life-threatening, yet commonly missed observation (2020) (3)
PET and PET-CT Imaging in Treatment Monitoring of Breast Cancer. (2009) (3)
Metabolic Tumor Volume on FDG-PET Predicts Clinical Outcomes Following Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of ECOG-ACRIN 6668/RTOG 0235 (2014) (3)
Differences in [ 99 mTc ] TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson ’ s disease (2013) (3)
Ring-shaped FDG uptake in the right lower lung: is it always a tumor? (2004) (3)
Effect of cerebral atrophy in positron emission tomography studies of aging and dementia (1990) (3)
18F-NaF Uptake in Calcified Uterine Leiomyoma. (2019) (3)
Alterations in cerebral glucose metabolism as measured by 18F-fluorodeoxyglucose-PET in patients with persistent postconcussion syndrome (2021) (3)
Radionuclide computerized tomography for brain study (1975) (3)
Synthesis of β-cell imaging agents (2001) (3)
Alzheimer's Disease at a Crossroad: Time to Part from Amyloid to More Promising Aspects- Atherosclerosis for a Start. (2022) (3)
Neuroimaging in Neurological Disorders (1996) (3)
Clinical value of 18F-FDG-PET/CT in suspected serious disease with special emphasis on occult cancer (2019) (3)
PET in Epilepsy and Other Seizure Disorders. (2010) (3)
Exploring Tumor Biology with Fluorodeoxyglucose-Positron Emission Tomography Imaging in Breast Carcinoma. (2009) (3)
Adrenocortical Positron Emission Tomography/PET-CT Imaging. (2007) (3)
Cardiac Assessment with PET. (2011) (3)
Assessment of regional glucose metabolism in aging brain and dementia with positron-emission tomography (1981) (3)
Association of baseline subject characteristics with changes in coronary calcification assessed by 18F-sodium fluoride PET/CT. (2021) (3)
Radiation Safety Concerns Related to PET/Computed Tomography Imaging for Assessing Pediatric Diseases and Disorders. (2020) (3)
Evolving Role of PET in Pediatric Disorders. (2020) (3)
Evaluation of the role of age and cardiovascular risk factors on FDG-PET/CT quantification of atherosclerosis in the thoracic aorta (2017) (3)
Scintigraphic demonstration of acute gastrointestinal bleeding (1980) (3)
Urolithoscintigraphy: preliminary report of a new imaging modality for urolithiasis. (1995) (3)
In Vivo Molecular Imaging of Musculoskeletal Inflammation and Infection. (2019) (3)
Coronary Molecular Calcification Calculated by Alavi-Carlsen Score (ACS) and its Correlation with Aging and Cardiovascular Risk Factors as Assessed by 18F-Sodium Fluoride PET/CT (2019) (3)
Volumetric parameters from [ 18F]FDG PET/CT predicts survival in patients with high‐grade gastroenteropancreatic neuroendocrine neoplasms (2022) (3)
Radionuclide fourier amplitude analysis to predict post-aneurysmectomy ejection fraction (1984) (3)
The study of the brain using PET and SPECT: implications for space and underwater neurology (1996) (3)
Patterns of 18 F-FDG PET images in patients with uncomplicated total hip arthroplasty (3)
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical Trial. (2022) (2)
Incidental congenital renal and ureteric anomalies in patients studied for neoplastic diseases. (2010) (2)
4775Diagnostic value of Positron emission tomography (PET/CT) in native and prosthetic infective endocarditis (2017) (2)
Comparison of contrast-enhanced CT, PET/CT, PET, and low-dose non-contrast enhanced CT imaging of diffuse large B-cell (DLBCL), follicular (FL), small lymphocytic/CLL (CLL/SLL), and marginal zone lymphomas (MZL). (2010) (2)
The Role of CT, MR Imaging, and Ultrasonography in Endocrinology. (2007) (2)
Pelvic horseshoe kidney mimics sacral metastases on bone scan. (2005) (2)
Facts and Fictions About [18F]FDG versus Other Tracers in Managing Patients with Brain Tumors: It Is Time to Rectify the Ongoing Misconceptions. (2022) (2)
A pilot trial to examine the effect of high-dose niacin on arterial wall inflammation using fluorodeoxyglucose positron emission tomography. (2015) (2)
PET and PET/CT in Pediatric Gastrointestinal Tract Oncology. (2008) (2)
Components of professional competence for nuclear medicine physicians. (2003) (2)
Impact of methodological factors on assessment of atherosclerotic plaques using 18F-FDG and 18F-NaF PET/CT (2014) (2)
Non-18F-FDG/18F-NaF Radiotracers Proposed for the Diagnosis and Management of Diseases of the Heart and Vasculature. (2021) (2)
Detection of extramedullary and extranodal involvement of leukemia with FDG-PET (2006) (2)
Inter-observer Variability Using ROVER® Software for Processing of Cerebral FDG-PET Studies (2015) (2)
A Pilot Study of FDG-PET/CT in Polycythemia Vera Using Global Analysis Techniques (2020) (2)
2 Basics of Fluorodeoxyglucose Radiochemistry and Biology (2009) (2)
An Evaluation of Preoperative and Postoperative Ventilation and Perfusion Lung Scintigraphy in the Screening for Pulmonary Embolism After Elective Orthopedic Surgery (1991) (2)
Quantification of the total bone marrow activity with FDG-PET in multiple myeloma before and after treatment: comparison with a control group (2017) (2)
QUANTIFICATION OF TMJ RHEUMATOID ARTHRITIS ON POSITRON EMISSION TOMOGRAPHY SCANS USING ROVER SOFTWARE (2020) (2)
Imaging of bone metastases in suspected recurrent breast cancer (2015) (2)
PET/Computed Tomography Using New Radiopharmaceuticals in Targeted Therapy. (2015) (2)
The Evolving Role of Positron Emission Tomography in Patients with Medullary Thyroid Carcinoma. (2007) (2)
New IDEAS Amyloid Imaging 2021 Study: Running in Place with Ineffective Anti-Amyloid Treatments for Alzheimer's Disease Patients. (2021) (2)
Cerebral Metabolic Changes in Patients with Brain Tumors Demonstrated by Positron Emission Tomography (1992) (2)
Radionuclide localization of gastrointestinal hemorrhage. (1982) (2)
The correlation between myocardial perfusion scintigraphy and three-dimensional echocardiography in ejection fraction and cardiac volumes for determination of the nearest filtering parameters (2019) (2)
The effect of aging on aortic atherosclerotic plaque inflammation and molecular calcification: A FDG and NaF PET CT imaging study (2013) (2)
An Update on the State of Tau Radiotracer Development: a Brief Review (2021) (2)
Evaluation of myeloma bone disease by means of 18F-sodium fluoride PET/CT (2019) (2)
PET Imaging of Pheochromocytoma. (2007) (2)
The Role of PET and PET/CT in the Surgical Management of Breast Cancer: A Review. (2009) (2)
Ocular Melanoma and Other Unusual Sites. (2011) (2)
FDG-PET/CT in venous thromboembolism (2018) (2)
Innovative applications of combined PET/MRI modality in diagnosis and follow-up of Multiple Sclerosis (2018) (2)
Economic sanctions are against basic human rights on health (2019) (2)
Thoracic aorta atherosclerosis in multiple myeloma patients assessed by18F sodium fluoride PET/CT (2019) (2)
Global brain glucose uptake on 18F-FDG-PET/CT is influenced by chronic cardiovascular risk. (2020) (2)
Utility of FDG-PET/CT in clinical psoriasis grading: the PET-PASI scoring system. (2020) (2)
Can Target-to-Background Ratio Measurement Lead to Detection and Accurate Quantification of Atherosclerosis With FDG PET? Likely Not (2022) (2)
Detection of myocardial viability with positron emission tomography in a patient with ischemic cardiomyopathy. (1991) (2)
(18)F-FDG-PET in restaging primary maxillary sinus melanoma with isolated gall bladder metastasis. (2009) (2)
Very low probability lung scan findings: A need for change (1997) (2)
Assessing Coronary Artery and Aortic Calcification in Patients with Prostate Cancer Using 18F-Sodium Fluoride PET/Computed Tomography. (2022) (2)
Multifaceted role of lymphatic mapping by SPECT/CT hybrid imaging in the multimodality management of patients with cancer (2009) (2)
Tau-PET imaging as a molecular modality for Alzheimer's disease. (2021) (2)
Measuring bone marrow activity with FDG-PET in multiple myeloma, smoldering myeloma, and healthy subjects (2018) (2)
Potential Applications of PET Scans, CT Scans, and MR Imaging in Inflammatory Diseases: Part II: Cardiopulmonary and Vascular Inflammation. (2020) (2)
Utility of FDG PET/CT in assessing bowel inflammation. (2021) (2)
Assessment of uptake of FDG in the whole bone marrow of multiple myeloma and smoldering multiple myeloma patients through a novel method of PET/CT quantification: comparison with a control group (2019) (2)
American Journal of Nuclear Medicine and Molecular Imaging: Editorial Board (2011) e-Century Publishing Corporation. (2011) (2)
Promising Roles of PET in Management of Arthroplasty-Associated Infection. (2012) (2)
An evaluation of the predictive value of mid-treatment 18F-FDG-PET/CT scans in pediatric lymphomas and undefined criteria of abnormality in quantitative analysis. (2013) (2)
Evolving Role of PET-Computed Tomography and PET-MR Imaging in Assessment of Musculoskeletal Disorders and Its Potential Revolutionary Impact on Day-to-Day Practice of Related Disciplines. (2018) (2)
How high can the standardized uptake value be? (2002) (2)
PET Scan in Thyroid Cancer. (2012) (2)
Global assessment of cardiovascular NaF uptake is superior to FDG in the era of atherosclerosis imaging (2017) (2)
Measurement of Local Cerebral Glucose Metabolism: Effect of Pathology and Functional Stimulation (1985) (2)
False-positive reversible septal myocardial perfusion defect caused by diaphragmatic hernia. (2007) (2)
Clinical significance of incidental focal bowel uptake on 18F-FDG PET/CT as related to colorectal cancer. (2016) (2)
Opinion on favoring labeled leukocyte imaging over 18 F-FDG-PET for diagnosing prosthetic joint infection : Rectifying ongoing misconceptions (2016) (2)
The Value of 18F-FDG PET/CT in the Assessment of Cardiac Malignancy Remains to Be Defined (2012) (2)
Artificial Intelligence in Vascular-PET:: Translational and Clinical Applications. (2022) (2)
Pre-treatment dual-time-point FDG-PET/CT imaging may predict response in patients with Crohn's disease (2013) (2)
Structural and functional changes in the adrenal glands with age as determined by FDG-PET and CT imaging (2007) (2)
Comparison of contrast-enhanced CT (CECT) and FDG-PET/CT for imaging diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) (2009) (2)
Absence of FDG uptake in a trauma patient with compromised vasculature as evidence of tissue nonviability. (2011) (2)
Modern Quantitative Techniques for PET/CT/MR Hybrid Imaging (2012) (2)
Pharmacokinetics, Dosimetry, and Initial Therapeutic Results with 131I- and lllIn-/9~ Humanized LL2 Anti-CD22 Monoclonal Antibody in Patients with Relapsed, Refractory Non-Hodgkin's Lymphoma I (2007) (2)
Applications of Hybrid PET/Magnetic Resonance Imaging in Central Nervous System Disorders. (2020) (2)
I‐123-IBZM: A CNS D2 RECEPTOR AGENT BIODISTRIBUTION & IMAGING IN HUMANS (1989) (2)
Utility of PET scan in predicting chemotherapeutic response in soft tissue sarcoma patients (2007) (2)
Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors (2022) (2)
The Role of Positron Emission Tomography- Computed Tomography/Magnetic Resonance Imaging in Modern Medicine (2014) (2)
Genetic fine structure analysis of Helicobacter pylori isolates before and after treatment. (2003) (2)
18F-FDG-PET/CT in the assessment of atherosclerosis in lung cancer. (2021) (2)
FDG PET/CT outperforms diagnostic CT in the initial staging of non Hodgkin's lymphoma (NHL) in pediatric patients (2009) (2)
Global and regional brain glucose metabolism decline after systemic chemotherapy (2015) (2)
Is planar imaging in radiology and nuclear medicine a viable option for the 21st century? (2008) (2)
CEREBRAL BLOOD FLOW DURING INTENSE MEDITATION MEASURED BY HMPAO-SPECT: A PRELIMINARY STUDY (1998) (2)
Cardiovascular Imaging with PET, CT, and MR Imaging. (2008) (2)
Systemic bone remodeling in multiple myeloma, smoldering myeloma, and healthy subjects: Global assessment with NaF-PET (2018) (2)
Evolving Role of PET in Interventional Radiology-Based Oncology Procedures. (2019) (2)
The heart or a tumor? Lung cancer in the lower left thorax can mimic myocardial FDG uptake on PET imaging. (2003) (2)
Dual time point 18F-FDG PET/CT in the evaluation of patients with suspected malignant lymphoma (2014) (2)
Prevalence of clinically significant incidental findings by whole-body fludeoxyglucose F 18 positron emission tomography/computed tomography scanning in moderate-to-severe psoriasis patients participating in clinical trials. (2019) (2)
Feasibility of using global FDG uptake in bone marrow to assess treatment of multiple myeloma (2017) (2)
Determination of Regional Cerebral Function and Structure in Normal Aging and Dementia with Positron Emission Tomography, Magnetic Resonance Imaging and X-Ray Computed Tomography (1986) (2)
A New Technic: Quantitative Global Disease Assessment of PET CT (2015) (2)
The Role of Lymphatic Mapping and Sentinel Lymph Node Biopsy in the Staging of Breast Cancer. (2009) (2)
Personalized Management Approaches in Lymphoma: Utility of Fluorodeoxyglucose-PET Imaging. (2016) (2)
Maximum Standard Uptake Value (SUVmax) on FDG-PET Imaging Predicts Time to First Treatment in Patients with Low Grade Follicular Lymphoma, (2011) (2)
Surgery for epilepsy. (1990) (2)
The role of FDG-PET in assessing osteoarthritis (2007) (2)
Evolving role of radiolabeled particles in detecting infection and inflammation, preliminary data with 99mTc-phytate in rats (2015) (2)
FDG-PET/CT as the superior imaging modality for inflammatory bowel disease (2020) (2)
Assessment of 18F‐NaF Positron Emission Tomography Imaging for Early Coronary Artery Calcification (2015) (2)
4 patient preparation (2009) (2)
A review of different methods used for quantification and assessment of FDG-PET/CT in multiple myeloma (2022) (2)
Quantitative autoradiography of parathyroid glands in rats with carbon-14-labeled amino acids. (1987) (2)
FDG-PET evaluation of patients with leukemia (2006) (2)
Gastrointestinal Nuclear Imaging (1988) (2)
Tau Imaging in Head Injury. (2021) (2)
PET-CT-MRI Applications of Musculoskeletal Disorders, Part I (2018) (1)
FDG activity in patients with painful hip prosthesis and quantitative analysis (2007) (1)
Evolving Role of Novel Quantitative PET Techniques to Detect Radiation-Induced Complications. (2020) (1)
Initial Clinical Experience with the CDR-grafted (humanized) LL2 anti-CD22 MAb against B-cell malignancies. (1998) (1)
Multimodality Imaging of a Pancreatic Transplant A Case Report (1990) (1)
A prospective 18F-fluorodeoxyglucose positron emission tomography/computed tomography study of the neurometabolic effects in cocaine use and HIV infection (2023) (1)
Physiologic and Metabolic Study of Pulmonary Disorders Using Conventional Imaging Techniques and Positron Emission Tomography (2015) (1)
Early Diagnosis of Avascular Necrosis by Magnetic Resonance Imaging (1990) (1)
Assessment of atherosclerotic plaque inflammation can be improved by delayed time point FDG PET CT imaging (2013) (1)
Molecular imaging in management of colorectal metastases by the interventional oncologist (2022) (1)
A COMPARISON OF VASCULAR INFLAMMATION IN RHEUMATOID ARTHRITIS, PSORIASIS AND HEALTHY CONTROLS BY FDG-PET/CT: A PILOT STUDY (2013) (1)
Novel quantitative measurement of pulmonary inflammation in COPD by FDG PET and CT segmentation (2009) (1)
Launch of the american journal of nuclear medicine and molecular imaging. (2011) (1)
Evaluation of response to gene therapy for malignant gliomas with FDG PET imaging and MRI (1998) (1)
Non-invasive assessment of tumor hypoxia with the 2-nitroimidazole 18F-EF1 and PET. (1999) (1)
Ventilation Abnormalities Associated with Pulmonary Embolism (1988) (1)
FDG-PET IMAGING: AN AID TO THE CLINICIAN IN THE MANAGEMENT OF PAINFUL HIP PROSTHESES. (1998) (1)
Multimodality Imaging Approach in Alzheimer disease (2015) (1)
Potential role of global quantitative FDG-PET image analysis in assessing temporal lobe epilepsy (2016) (1)
Application of 18F-NaF-PET/CT in assessing age-related changes in the cervical spine. (2021) (1)
Synthesis and first evaluation of new 18F‐labelled sulfonylureas for the determination of the beta‐cell status in vivo (2001) (1)
8 Cardiovascular System Scintigraphy (2013) (1)
Dual Time Point FDG-PET/CT Imaging Can Distinguish Between Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma (2014) (1)
Gene Therapy and Local Drug Delivery (2000) (1)
Atherosclerosis Imaging: Positron Emission Tomography. (2023) (1)
Evolving Role of FDG-PET Imaging in the Management of Patients with Suspected Infection and Inflammatory Disorders (2006) (1)
The Comparison of Acetic Acid and Strontium Chloride Procedures for Extraction of Hemin (2007) (1)
Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: An ROC analysis. (1999) (1)
CEREBRAL FUNCTIONAL ACTIVITY MAPPED WITH 18F-2-DEOXY-2-FLUORO-D-GLUCOSE (1982) (1)
23 Urologic Tumors (2009) (1)
Coupling of Inflammation and Microcalcification in the Pathogenesis of Prostate Calculi: Detection Using 18F-NaF and 18F-FDG PET/CT. (2022) (1)
Correlation between quantified breast densities from digital mammography and 18F-FDG PET uptake (2010) (1)
Dynamics of fluorine-18-fluorodeoxyglucose uptake in the liver and its correlation with hepatic fat content and BMI (2019) (1)
Dual-Energy CT with Fast-kVp Switching and Its Applications in Orthopedics (2013) (1)
Baseline global splenic uptake of FDG in multiple myeloma patients: a higher uptake is associated with inferior overall survival (2019) (1)
HMPAO-SPECT imaging during intense Tibetan Buddhist meditation (1995) (1)
Novel Quantitative PET Imaging Techniques in Tuberculosis. (2020) (1)
PET/MRI: Clinical Applications (2016) (1)
Correlation of hyperlipidemia with high degree of FDG uptake in human aorta (2006) (1)
FDG-PET in patients with fever of unknown origin (2006) (1)
The role of hepatobiliary imaging in the evaluation and management of patients with common bile duct gallstones. (1991) (1)
FDG PET as a prognostic tool for treatment response in cholangiocarcinoma (2020) (1)
Ventral hernia resulting in increased fluorodeoxyglucose uptake on positron emission tomographic imaging. (2002) (1)
Quantifying metabolic activity of the spleen in patient with multiople myeloma using 18F-FDG-PET/CT: comparison to normal subjects and evaluation of the effect of the high-dose chemotherapy (2018) (1)
Pediatric Cardiac PET Imaging. (2008) (1)
Abstract 14521: Association of Serum Leptin and Abdominal Aortic Inflammation in Rheumatoid Arthritis (2020) (1)
Hybrid PET Imaging in Neurologic Disease: PET/MRI Rather than PET/CT (2011) (1)
Thallium-201 SPECT in neuro-oncology (1997) (1)
Comparison of FDG-PET and CT in detection of neoplasia in patients with paraneoplastic neurologic syndrome (PNS) (2008) (1)
Comparison of Contrast-Enhanced CT, PET/CT, PET, and Low-Dose Non-Contrast Enhanced CT Imaging of Diffuse Large B-Cell, Follicular, Small Lymphocytic/CLL, and Marginal Zone Lymphomas. (2009) (1)
Erratum to “Synthesis and evaluation of fluorine-18 labeled glyburide analogs as β-cell imaging agents” [Nucl. Med. Biol. 2004;31: 483–491] (2005) (1)
Quantification of FDG uptake of the joints in rheumatoid arthritis and correlations with clinical disease activity using volumetric PET/CT parameters (2015) (1)
Detection of relapse in diffuse large B-cell lymphoma (DLBCL) and Hodgkin's lymphoma (HL): Observations and implications for post-remission combined PET and CT images radiologic surveillance (2007) (1)
I-123 as an optimal diagnostic imaging agent in differentiated thyroid carcinoma: A comparison with I-131 post-treatment scanning (2006) (1)
Recovery of Function after Focal Cerebral Insult (1994) (1)
Role of [F-18] 2-Deoxy-2-Fluoro-d-Glucose PET and PET/CT in Staging and Follow-Up of Breast Cancer. (2009) (1)
Normal tissue FDG uptake in patients with compromised renal function (2014) (1)
Positron emission tomography in the investigation of neuropsychiatrie disorders: Update and comparison with magnetic resonance imaging and computerized tomography (1991) (1)
[Impact of the correction of the attenuation in myocardial perfusion image with SPECT]. (1998) (1)
[Does semi-quantitative analysis of FDG-PET have any additional value in the diagnosis of mesial temporal sclerosis?]. (2001) (1)
[Study of myocardial viability by positron emission tomography]. (1998) (1)
Introduction on Nuclear Medicine and Immunology (2021) (1)
Comparison of global uptake of NaF-PET/CT in whole-body bone in multiple myeloma and healthy controls (2017) (1)
Positron Emission Tomography in Medicine: An Overview (2008) (1)
A genetic model of esophageal cancer accurately portrays clinical FDG uptake (2006) (1)
Role of NaF PET-CT in Quantifying Total Body Atherosclerotic Burden In Major Arteries (2020) (1)
PET Assessment of Brown Fat. (2011) (1)
DETERMINATION OF CEREBRAL BLOOD FLOW CORRELATES OF ACUPUNCTURE USING Tc-99M HMPAO SPECT IMAGING (1998) (1)
Role of Global Disease Assessment by Combined PET-CT-MR Imaging in Examining Cardiovascular Disease. (2011) (1)
10 Oncologic PET by Anatomical Region (2009) (1)
SPECT IMAGING OF DOPAMINE D2 RECEPTORS WITH 123I‐IBZM IN NORMAL CONTROLS AND AFTER DIFFERENT DOSES OF HALOPERIDOL (1992) (1)
Comparison of radionuclide (RN), computed tomography (CT) and magnetic resonance (MR) imaging of a vascular necrosis (AVN) of the hip using receiver operator characteristic (ROC) curves (1985) (1)
Assessment of treatment response of cardiac and extra-cardiac sarcoidosis by using metabolic and volumetric FDG PET/CT parameters (2014) (1)
Editorial [Hybrid Imaging (Guest Editors: Birger Hesse and Abass Alavi)] (2011) (1)
Imaging Evaluation of Cutaneous Lymphoma Using Functional and Structural Imaging (2016) (1)
Positron Emission Tomography-Based Assessment of Cognitive Impairment and Dementias, Critical Role of Fluorodeoxyglucose in such Settings. (2022) (1)
Diagnostic performance of volumetric FDG-PET/CT parameters in the detection of deep vein thrombosis (2014) (1)
Evolving role of FDG and NaF-PET/CT in early detection of peripheral artery diseases (2017) (1)
Molecular imaging of brain tumor: A review of available PET and MRI biomarkers (2016) (1)
Effects of chemotherapy on brain glucose metabolism in patients with multiple myeloma (2017) (1)
New noninvasive tests forHelicobacter pylori gastritis (1996) (1)
PET-Based Molecular Imaging in Evolving Personalized Management Design (2016) (1)
Neuroimaging II (1996) (1)
04:03 PM Abstract No. 235 Pre-treatment FDG-PET can predict the survival after Yttrium-90 radio-embolization in metastatic liver disease (2019) (1)
The FDG-PET Revolution of Medical Imaging – Four Decades and Beyond (2015) (1)
Assessment of the correlation between pulmonary parenchymal inflammation and pulmonary function test indices in COPD patients using partial volume corrected FDG-PET/CT parameters (2018) (1)
False-negative interpretation of FDG positron emission tomography in a patient with Hodgkin's lymphoma. (2002) (1)
A prospective 18F-FDG PET/CT study of the neurometabolic effects in cocaine use and HIV infection. (2023) (1)
FUNCTIONAL STUDIES OF THE GASTROINTESTINAL TRACT (1982) (1)
Radiation dosimetry of 2 (/sup 18/F)fluoro-2-deoxy-D-glucose in man (1982) (1)
Implementation of FDG-PET/CT imaging methodology for quantification of inflammatory response in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial. (2021) (1)
[Brain hypometabolism in patients with mesial-temporal sclerosis demonstrated by FDG-PET]. (2000) (1)
The overall impact of amyloid PET on diagnosis and management of dementia (2019) (1)
Benefit of time-of-flight information for whole-body FDG PET (2006) (1)
$^{201}Thallium SPECT in neuro-oncology (1997) (1)
Critical Role of 18F-Labeled Fluorodeoxyglucose PET in the Management of Patients with Arthroplasty. (2006) (1)
Prognostic significance of conventional and volumetric PET parameters with and without partial volume correction in the assessment of head and neck squamous cell carcinoma (2022) (1)
NMR Imaging of the Abdomen at 0.12 T: Initial Clinical Experience with a Resistive (1983) (1)
Abstract MP24: Correlation Between Blood Pressure And Inflammation In The Thoracic Aorta Of HIV Patients With And Without Cocaine Use As Assessed By FDG-PET/CT (2020) (1)
Effects of systemic chemotherapy on cervical spinal cord FDG uptake (2007) (1)
2018 Eastern Regional Meeting (2018) (1)
Adverse effects of edema on adjacent gray matter function in patients with brain tumor as determined by FDG-PET imaging. (1999) (1)
Potential applications of FDG-PET/MRI in detecting vascular dementia (2020) (1)
Role of Nuclear Imaging in Detecting and Assessing Chemotherapy Induced Cardiotoxicity (2020) (1)
Assessment of bone turnover in multiple myeloma patients before and after treatment (2018) (1)
073_17038P-C4 Characterization of the Electroanatomic Substrate in Cardiac Sarcoidosis and its Correlation with Imaging Findings of Scar and Inflammation (2017) (1)
The effect of breast density on FDG uptake and its change over time in normal breast tissue (2006) (1)
Oncogene pathway activation in mammary tumors dictates [ 18 F]-FDG-PET uptake (2014) (1)
Study on the correlation of atherosclerosis in the popliteal artery with metabolic activity and metabolic volumetric product of the diabetic foot (2008) (1)
Atherosclerosis Burdens in Diabetes Mellitus: Assessment by PET Imaging (2022) (1)
Utility of F-FDG PET/CT in pre-surgical risk stratification of patients with breast cancer (2019) (1)
Role of PET imaging in immunotherapy (2018) (1)
Advances in the PET/CT and PET/MRI hybrid imaging: An update on instrumentation and techniques of quantitation (2016) (1)
Development of a novel quantitative approach for evaluation of cardiac calcification using 18F-NaF PET/CT (2017) (1)
The evolving role of PET/CT and PET/MRI in the management of sarcoidosis (2014) (1)
Nonprosthesis Orthopedic Applications of (18)F Fluoro-2-Deoxy-d-Glucose PET in the Detection of Osteomyelitis. (2006) (1)
Prognostic Value of FDG-PET in Lymphoma Patients Undergoing Autologous Stem Cell Transplantation. (2005) (1)
Does intense myocardial uptake of fasting FDG-PET scan indicate cardiac disease? (2006) (1)
Role of FDG-PET in the evaluation of tumors treated with radiofrequency ablation (2008) (1)
Altered Metabolic Activity Of The Genioglossus And Soft Palate In Patients With Obstructive Sleep Apnea Using FDG-PET Imaging (2012) (1)
Value of (18)F NaF PET/CT in the Detection and Global Quantification of Cardiovascular Molecular Calcification as Part of the Atherosclerotic Process. (2012) (1)
Emission computerized-tomography and determination of local brain function (1975) (1)
Single Photon Emission Computed Tomography (SPECT): Technique (2009) (1)
Absolute right and left ventricular volume and ejection fraction measurements by tomographic MUGA (1996) (1)
FDG-PET of poststroke oculomotor repair (2004) (1)
Deteriorating effects of cocaine abuse on brain metabolic function of HIV infected patients (2016) (1)
Author ' s personal copy Current Trends in PET and Combined ( PET / CTand PET / MR ) Systems Design (2008) (1)
PET Imaging of Thoracic Disease. (2011) (1)
Global quantification of NaF in the skeleton: assessing bone formation in multiple myeloma patients before and after treatment (2017) (1)
Can Tumor FDG-PET Scan Uptake (SUV) Predict Local Control in Stage III NSCLC? Preliminary Results from ACRIN 6668/RTOG 0235 (2011) (1)
Diagnostic imaging using 18F-labeled L-fluoro-DOPA PET scans assists in treatment planning for pediatric patients with hyperinsulinism (2006) (1)
A PET study of cerebellar metabolism in normal and abnormal states (1985) (1)
Normal Variants and Effects of Aging on the Gastrointestinal Tract. (2008) (1)
Assessment of the diagnostic performance of quantitative FDG-PET/CT parameters in the detection of vascular graft infection (2015) (1)
Is 18F-FDG PET/CT a valuable diagnostic tool for verifying accelerated atherosclerosis secondary to diabetes mellitus on insulin in the aortic segments and large arteries? (2017) (1)
Changes in metabolic activity of malignant pleural mesothelioma on dual time point FDG-PET (2008) (0)
Beta cell imaging: State of the art and knowledge gaps (2014) (0)
Comprar Endocrinology, An Issue of PET Clinics | Abass Alavi | 9781416060918 | Saunders (2008) (0)
FDG-PET in detecting the primary and recurrent salivary gland cancers (2006) (0)
Review Article The role of molecular imaging in diagnosis of deep vein thrombosis (2014) (0)
COMPARISON OF BONE MINERAL DENSITY OF THE SPINE WITH DPA AND QUANTITATIVE CT IN PATIENTS WITH OSTEOPOROSIS (1987) (0)
New observation of early detection of venous thromboembolism by 18F-FDG PET/CT scans in patients with multiple myeloma (2014) (0)
In vivo and in vitro biodistribution of iodine 123 ibzm a potential cns d 2 dopamine receptor imaging agent (1988) (0)
6 Skeletal System Scintigraphy (2013) (0)
Effects of a 9 @ Tc-Labe 1 edMurineImmunoglobulin M Antibody to CD 15 Antigens on Human Granulocyte Membranes in Healthy Volunteers (2006) (0)
What is the optimal route of administration of 18F-FDG and 11C-Choline for PET imaging in small animals? (2006) (0)
Assessment of molecular calcification in the arterial wall of various cardiovascular risk subgroups by NaF-PET imaging (2013) (0)
How does age affect the testicular volumetric and metabolic changes (2007) (0)
Assessing global 18F-sodium fluoride uptake as an index for degenerative joint disease activity in hands and feet (2016) (0)
13 Head and Neck Cancer (2009) (0)
FDG-PET and MRI findings of neurodegenerative osteoarthropathy in the diabetic foot (2008) (0)
Viscerally Induced Cutaneous Vasospasm (1985) (0)
tructural and Functional Imaging of Normal Bone arrow and Evaluation of Its Age-Related Changes (2007) (0)
Acknowledgement to Reviewers (2016) (0)
8 The Value of PET/CT (2009) (0)
Potential clinical utility of partial volume correction of standardized uptake value in evaluating breast carcinoma by FDG-PET (2007) (0)
FDG PET in the management of lung cancer (1997) (0)
Comparison of anatomic and metabolic tumor imaging in head and neck squamous cell cancer (HNSCC) (2001) (0)
Erratum: Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis (2000) (0)
Appendix 9 Answers to Chapter 9 (2013) (0)
PET and PET/CT. A clinical guide, Thieme New York – Stuttgart 2006 190 pages (2006) (0)
Appendix 16 Answers to Chapter 16 (2013) (0)
Prostate Cancer (2022) (0)
NaF-PET/CT for assessment of temporomandibular joint osseous activity in rheumatoid arthritis patients and healthy subjects (2019) (0)
Acute Disseminated Encephalomyelitis (2006) (0)
Diuretic renography in late occurrence of hematoma after renal transplantation. (2004) (0)
PET-CT image segmentation: An inevitable step in translational medical imaging research (2013) (0)
University of Southern Denmark Correlation of whole-bone marrow dual-time-point 18F-FDG, as measured by a CT-based method of PET/CT quantification, with response to treatment in newly diagnosed multiple myeloma patients (2020) (0)
Corrected liver SUV using lean body weight and body surface area increases with age independently of other factors (2006) (0)
Single photon emission computed tomography imaging of the brain: Prospects for the 90's (1992) (0)
Bone scintigraphy in diabetic osteoarthropathy. [/sup 99m/Tc-methylene diphosphonate] (1981) (0)
Evaluation of Musculoskeletal with PET, PET/ CT , and PET/ MR Imaging (2009) (0)
Functional Neuroimaging: A Transformative Tool for Integrative Psychiatry (2018) (0)
Overview of the Nuclear Medicine Manuscipts Published in JCAM (2016) (0)
Psoriasis is associated with increased aortic inflammation as measured on FDG-PET/CT - A novel observation (2011) (0)
Assessment of delayed FDG-PET/CT for optimized visualization of atherosclerotic plaque: A new observation (2012) (0)
Significant difference in dual time point PET findings: Hodgkin disease vs. non-Hodgkin lymphoma (2013) (0)
Increasing level of FDG uptake in shoulder, hip, and knee joints with aging: age related inflammation in the joints (2017) (0)
A New MyocardialImagingAgent: Synthesis, Characterization, Biodistributionof Gaffium-68-BAT-TECH (1990) (0)
FDG uptake in the normal liver does not change over 2 years (2018) (0)
Nuclear Medicine: The Essentials (2022) (0)
FDG-PET/CT imaging for assessment of maxillary sinus mucosal membrane lesions (2019) (0)
Author’s comment on the retraction of “Neuroradiological advances detect abnormal neuroanatomy underlying neuropsychological impairments: the power of PET imaging” (2014) (0)
Diagnostic performance of FDG-PET in differentiating septic from aseptic painful knee prostheses. (2009) (0)
Evolving Role of PET in Assessing the Efficacy of Immunotherapy and Radiation Therapy in Malignant Disorders (2020) (0)
Application of PET/CT in psoriatic arthritis (2019) (0)
006—18[F]-Flourodopa PET Scan to Localize Focal Lesions in Congenital Hyperinsulinism (2007) (0)
Syddansk Universitet Quantification of FDG-PET / CT with delayed imaging in patients with newly diagnosed recurrent breast cancer (2018) (0)
15 Thoracic Neoplasms (2009) (0)
Cerebral blood flow effects in long-term meditators (2007) (0)
Acknowledgement to Reviewers (2015) (0)
Effects of age and cardiovascular risk factors on FDG-uptake in atherosclerotic plaques in aorta and peripheral arteries (2012) (0)
Evaluation of diagnoses and tumor volumes using FDG-PET, MRI, mammogram and pathological tests in breast cancer (2004) (0)
Primary brain tumor imaging biomarkers: a review of currently available PET and MR techniques (2015) (0)
Gastrointestinal Nuclear Imaging. Volume 7, Contemporary Issues (1989) (0)
SNM Participates in IAEA Symposium in Brazil. (2004) (0)
Right Heart Score for Predicting Outcome in€PAH (2016) (0)
DEAFFERENTATION IN PATIENTS WITH TEMPORO-MESIAL SCLEROSIS MEASURED BY FDG PET. (1999) (0)
Superior vena cava as the most optimal site for background correction in quantification of atherosclerosis (2013) (0)
Diagnosing recurrent breast cancer: Accuracy and inter-rater agreement of FDG-PET/CT and bone scintigraphy (2017) (0)
Gas exchange abnormalities in patients with congestive heart failure (CHF) correlate with increased lung density (1997) (0)
Imaging of congenital hyperinsulinism with 18F-L-Fluoro-DOPA PET and correlation with histopathology (2006) (0)
Potential Role of FDG-PET Imaging in Defining Biology of Primary Breast Lesions (2008) (0)
Critical Role of PET in Assessing Age Related Disorders (2023) (0)
New Concepts for Assessing Global Organ Function and Disease Activity Based on Combined PET and Structural Imaging Techniques. (2007) (0)
THE SUPERIORITY OF INDIUM‐111 WHITE BLOOD CELL SCINTIGRAPHY OVER THREE‐PHASE BONE SCINTIGRAPHY IN THE DIAGNOSIS OF PEDAL OSTEOMYELITIS IN DIABETICS (1989) (0)
The value of partial volume correction in the detection of the primary breast cancer (2006) (0)
Assessment and quantification of psoriasis disease activity using FDG-PET/CT: A novel concept (2013) (0)
The role of structural-metabolic scan fusion for image-guided interventions: Biopsy of suspected malignancy (2007) (0)
Dual time point FDG-PET imaging in patients with newly diagnosed breast cancer (2007) (0)
Automated calculation of gallbladder ejection fraction (2004) (0)
Dual-time FDG-PET/CT imaging in suspected ovarian cancer (2015) (0)
FDG-PET/CT for evaluation of inflammation in the lumbar spine following surgery for lumbar disc herniation (2017) (0)
FDG PET/CT imaging : normal variations and benign findings (2014) (0)
20 Hepatobiliary Tumors (2009) (0)
In vivo displacement of CNS D1 and D2 receptor binding measured by spect imaging (1992) (0)
Arthroplasty-associated infection: Novel role of FDG-PET and other diagnostic modalities in the management (2013) (0)
A 360 degree acquisition protocol during TC-99 sestamibi and SPECT improves regional tracer distribution (1997) (0)
Detection and global quantification of cardiovascular molecular calcification by 18F-Fluoride PET/CT (2011) (0)
Tomographic gated blood pool imaging of the brain; A new method for assessing cerebral hemodynamics (1997) (0)
Gr upSM Nuclear Medicine Imaging for Evaluation of Low Back Pain (2016) (0)
A BASAL GANGLIA PHANTOM FOR 1–123‐IBZM SPECT QUANTITATION (1989) (0)
24 Colorectal Cancer (2009) (0)
NaF-PET Imaging of Atherosclerosis Burden (2023) (0)
The value and limitations of SUV measurements and method to enhance their utility. (2000) (0)
Comprar Instrumentation, An Issue of PET Clinics,2-2 | Abass Alavi | 9781416049883 | Saunders (2007) (0)
The Role of FDG-PET Imaging in Diagnosing Periprosthetic Infection After Total Hip Arthroplasty (2006) (0)
CORRELATIVE MR AND SCINTIGRAPHIC THYROID IMAGING (1987) (0)
P19. Malignant pleural mesothelioma: evaluation with 18F-FDG PET (2003) (0)
Usefulness of FDG-PET/CT for tumour thrombosis (2014) (0)
In-vitro and in-vivo evaluation of [18F]fluorethoxy-bromo-glibenclamide for the non invasive visualisation of the pancreatic islet cell mass in humans using PET (2004) (0)
PET for Measuring Therapy Response After Radionuclide Therapy (2012) (0)
Appendix 19 Mock Examination Answers (2013) (0)
The role of volumetric 18F-NaF PET/CT parameters in assessment of treatment response in patients with spinal stenosis undergoing spinal fusion surgery. (2015) (0)
Complex PartialEpilepsy:The Role of Neuroimagingin Localizing a SeizureFocus for SurgicalIntervention (1990) (0)
Atherosclerotic plaques are more prevalent in infradiaphragmatic aorta than thoracic aorta as revealed by FDG-PET/CT (2012) (0)
Nuclear Medicine-A Name for Now and the Future. (2023) (0)
18F-FDG-PET/CT in Multiple Myeloma: High Intense PET Positive Lesions at Diagnosis Harbor Cytogenetic Adverse Subclones (2016) (0)
Post-Excisional Biopsy Seroma on FDG-PET Scan in Patients with Breast Cancer Can Conceal Residual Malignancy (2005) (0)
Recent Advances in Imaging with PET, Computed Tomography, and MR Techniques. (2020) (0)
Measured attenuation correction in whole-body PET : essential and simple. (2000) (0)
Trial by design: How computer simulation effected a major change in a proposed multi-institutional study (1998) (0)
ROLE OF FDG PET IN EVALUATION OF HEPATOCELLULAR CARCINOMA (2005) (0)
Precision Imaging of Prostate Cancer. (2022) (0)
Potential utility of dual time point FDG-PET/CT imaging in pancreatic cancer (2010) (0)
Total hemispheric glycolysis ratio by FDG-PET/CT in gliomas; Evaluating diaschisis and potential prognostic information (2016) (0)
The relationship of FDG uptake and its change over time with receptor state and type of the primary breast cancer (2006) (0)
PET-based neuroimaging biomarkers: The pivotal role of brain atlases in accurate quantification (2013) (0)
The Role of Scintigraphyin the Managementof InflammatoryBowel Disease (1991) (0)
FDG PET/CT for the assessment of malignant and benign HIV-associated neurologic complications (2016) (0)
Application of PET/CT for evaluation of non-malignant disorders of the thorax (2014) (0)
Brain FDG-PET and MRI features in paraneoplastic neurological syndromes (PNS): Correlation with clinical manifestations (2007) (0)
I-123 imaging after recombinant human thyroid-stimulating hormone to diagnose metastatic disease in an intubated patient with papillary thyroid cancer. (2002) (0)
10 Gastrointestinal Tract Scintigraphy (2013) (0)
Positron imaging of intravenous O-15 labeled water for cerebral blood flow (1984) (0)
Perivesicle Pheochromocytoma: The Role of Iodine- 13 1-MIBG Imaging (2006) (0)
Relationship between camera physical characteristics and clinical performance of patient studies: an evaluation of two dedicated PET systems. (2000) (0)
Inverse correlation between hexokinase activity and glucose-6-phosphatase activity in ovarian cancer (2015) (0)
3 Radiation Safety (2013) (0)
PET-CT-MR Imaging-Based Cardiovascular Imaging. (2019) (0)
Appendix 7: Answers to Chapter 7 (2013) (0)
7 The Interpretation of FDG PET Studies (2009) (0)
Syddansk Universitet Cancer metastasizes to the bone marrow and not to the bone time for a paradigm shift ! (2018) (0)
Achievements and beyond: Scientific trajectory of Professor Mohammad A. Rafi (2020) (0)
PET Radiotracers in oncology other than 18F-FDG (2020) (0)
PET tumor volume assessment with different CT patient positions in lung cancer (2006) (0)
Clinical significance of incidental focal vs diffuse thyroid uptake on FDG-PET/CT (2008) (0)
Appendix 1 Mock Examination (2013) (0)
Multiple-Hospital Surveyof Ejection-Fraction VariabilityUsing a CardiacPhantom (1985) (0)
Current Status and Future Prospects in Breast Carcinoma of Positron Emission Tomography (2010) (0)
Molecular imaging in atherosclerosis (2022) (0)
FDG PET/CT versus bone marrow biopsy in bone lesions in pediatric patients with non-Hodgkin's lymphoma (2010) (0)
The performance of FDG-PET imaging for detecting and staging of axillary lymph node metastasis compared to sentinal node based biopsy results (2007) (0)
Local and remote effects of acute ischaemic infarction on cerebral glucose metabolism in man (1987) (0)
Dual time point imaging using 18F-FDG PET/CT in primary brain tumors - A pilot study (2012) (0)
Reviewer Acknowledgements 2018 (2018) (0)
FREQUENCY AND DEGREE OF SPATIAL MISREGISTRATION OF LESIONS IN PET-CT IMAGES AS A FUNCTION OF ANATOMICAL REGION AND LESION SIZE (2005) (0)
Commentary on “Treatment Outcome of Lung Cancer Patients as Optimized by Preoperative Whole-Body Positron Emission Tomography Fluorodeoxyglucose Imaging” (2000) (0)
Scintigraphic studies of F(ab')2 in human tumor xenografts in mice (1984) (0)
Early stage assessment of intrabronchial valve placement by Xe ventilation/Tc MAA perfusion scintigraphy in patients with severe emphysema (2006) (0)
Quantitative imaging of congenital hyperinsulinism with 18F-L-Fluoro-DOPA PET (2007) (0)
Quantification of FDG PET/CT dual-time-point imaging in recurrent breast cancer lesions (2016) (0)
The utility of PET imaging in the diagnosis and management of psychosis: a brief review (2021) (0)
Structural and functional changes in lung with increasing body mass index (BMI) (2007) (0)
Role of FDG-PET in detecting residual/recurrent brain tumor in post-operative pediatric patients with inconclusive MRI (2006) (0)
VISUALIZATION OF THE MOTOR EFFERENT PATHWAY WITH HMPAO SPECT AND TRANSCRANIAL MAGNETIC STIMULATION (1995) (0)
CORRELATION BETWEEN AGE AND PULMONARY ARTERY CALCIFICATION: A NOVEL FINDING ASSESSED BY 18F NAF-PET/CT (2020) (0)
Prevalence of clinically significant incidental findings by whole-body FDG-PET/CT scanning in moderate-to-severepsoriasis patients participating in clinical trials (2019) (0)
The role of 18F-FDG PET/CT in primary cutaneous lymphoma: an educational review. (2023) (0)
Diagnosing different Parkinsonian movement disorders with 99mTcTRODAT-1 (2001) (0)
18 Multimodality Imaging (2013) (0)
27 PET and PET/CT in Radiation Therapy Planning (2009) (0)
Deep venous thrombosis and pulmonary embolism. (1991) (0)
Increased 18F-fluoro-L-DOPA (F-DOPA) uptake by neuroblastoma (2006) (0)
Effect of Cocaine Abuse on Baseline Lung FDG uptake in Patients Receiving Highly Active Antiretroviral Therapy (2016) (0)
Optimizing the FDG PET Method to Assess Malignancy Through SUV Measurements (1996) (0)
FDG-PET Imaging for Radiation Therapy in Head and Neck Cancer (2000) (0)
Pneumectomy (volume reduction) for COPD: Assessment of results with quantitative V/Q scanning (1996) (0)
Molecular Imaging Assessment of Hormonally Sensitive Breast Cancer: An Appraisal of 2-[18F]-Fluoro-2-Deoxy-Glucose and Newer Non-2-[18F]-Fluoro-2-Deoxy-Glucose PET Tracers. (2022) (0)
Appendix 3 Answers to Chapter 3 (2013) (0)
Appendix 14: Answers to Chapter 14 (2013) (0)
Reading which FDG-PET images: Attenuation Corrected or Non Attenuation Corrected? A question forever (2005) (0)
Serum LDH predicts response rate, response duration, and survival of patients (pts) with relapsed/refractory non-Hodgkin's lymphoma (NHL) treated with 131I-tositumomab (131I-Tab) or 90Y ibritumomab tiuxetan (90Y-Iab) radioimmunotherapy (RIT). (2006) (0)
1 The Physics of PET/CT Scanners (2019) (0)
17 Gastric, Esophageal, and Gastrointestinal Stromal Tumors (2009) (0)
19TH ANNUAL NORTHEAST REGIONAL SCIENTIFIC MEETING GREATER NEW YORK (2006) (0)
Other PET Tracers and Prospects for the Future. (2011) (0)
THE DIFFERENTIATION OF INFARCTION FROM INFECTION IN SICKLE CELL DISEASE (2013) (0)
University of Southern Denmark Clinical value of 18F-FDG-PET/CT in suspected serious disease with special emphasis on occult cancer Caspersen, (2019) (0)
Effect of blood glucose level on standardized uptake value ( SUV ) in F-18-FDG PET-scan (0)
FDG-PET/CT vs. Non-FDG Tracers in Less Explored Domains (2022) (0)
Role of NaF-PET/CT in Detecting and Quantifying Global Cardiac Subclinical Atherosclerosis in Healthy Individuals with an Optimal Lipid Profile and its Association with Blood Pressure (2020) (0)
A Case of Thrombocytopenia Associated with Valporic Acid Treatment in a patient with Generalized Myoclonic Seizures (0)
Stomach uptake in FDG PET scans: is it related to blood glucose level ? (1998) (0)
Total metabolic Index; Inter-rater variability in quantifying cerebral hemispheric glucose metabolism in the course of treatment of glioma (2015) (0)
13 Infection Scintigraphy (2013) (0)
The Future of PET-MRI Beyond “PET Plus MRI” (2020) (0)
Detection of infected knee arthroplasty using FDG-PET (2008) (0)
The evolving role of volumetric PET/CT parameters for prognostication in patients with lung cancer (2015) (0)
Clinical applications of PET/MRI for evaluation of cardiovascular disease (2014) (0)
New trends in nuclear neurology and psychiatry (1994) (0)
Metabolic unit volume: A quantitative method for assessing the efficacy of cancer treatment using FDG PET/CT (2008) (0)
Can the maximum SUV and number of metastases on PET imaging be used to predict patient survival in soft tissue sarcoma (2007) (0)
Global quantification of coronary artery calcification in rheumatoid arthritis (2019) (0)
DETECTION OF BONE METASTASIS WITH FDG-PET USING STANDARD UPTAKE VALUE (SUV) AND VISUAL ANALYSIS. (1999) (0)
A critical review of the utility of PET imaging in the diagnosis and management of psychosis (2021) (0)
Pet Imaging in Pediatric Patients (2020) (0)
Local versus central review of SUVpeak for stage III NSCLC (2009) (0)
Evaluation of the Role of Aging on Calcification in the Aortic Wall Using NaF PET/CT (2016) (0)
Age-related decrease in cardiopulmonary adrenergic neuron function in children as assessed by 123I-metaiodobenzylguanidine (MIBG) imaging (2007) (0)
DETECTION OF PHEOCHROMOCYTOMA: I-131-MIBG, CT, MRI CORRELATION (1987) (0)
Quantification of aging effects upon knee joint global joint inflammation (GJI) by FDG-PET (2011) (0)
Appendix 6 Answers to Chapter 6 (2013) (0)
Promising role of FDG-PET imaging in management of patients with suspected infection (2000) (0)
Bone scan evaluation of degenerative joint disease of the spine. (1982) (0)
Is absolute whole brain glucose metabolism a sensitive marker for alzheimers disease (1992) (0)
PET Imaging for Immunotherapy and Radiation Therapy. (2020) (0)
etermination of Age-Related hanges in Structure and Function of Skin , dipose Tissue , and Skeletal Muscle With omputed Tomography , Magnetic Resonance maging , and Positron Emission Tomography (2007) (0)
14 Thyroid, Parathyroid, and Salivary Gland Scintigraphy (2013) (0)
Assessment of diagnostic performance of volumetric PET/CT parameters in treatment response monitoring of cardiac sarcoidosis (2014) (0)
University of Southern Denmark Diagnostic manifestations of total hemispheric glucose metabolism ratio in neuronal network diaschisis diagnostic implications in Alzheimer’s disease and mild cognitive impairment (2019) (0)
etection of Age-Related hanges in Thoracic Structure and Function y Computed Tomography , Magnetic Resonance maging , and Positron Emission Tomography (0)
Atlas of Skeletal Trauma (1992) (0)
In summary, FDG-PET has been shown to be cliniciilly effective in diagnosing suspected chronic osteomyelitis, infection associated with hip arthr~pl~asty, and fever of unknown origin. We strongly urge CMS to establish a coverage policy for these indications. (2006) (0)
A higher increase in FDG uptake in whole bone marrow of multiple myeloma patients from early to delayed pre-treatment scans is associated with poor response to treatment and inferior survival (2019) (0)
Polymeric nanocarriers co-encapsulating PET probes and protein therapeutics (2022) (0)
Appendix 2 Answers to Chapter 2 (2013) (0)
9 Levels of Evidence for Clinical Indications of FDG PET (2009) (0)
12 Oncologic Scintigraphy (2013) (0)
Tumour thrombosis: A novel application for FDG-PET/CT (2014) (0)
Quantitative whole-body PET/CT imaging (2019) (0)
The use of FDG-PET/CT to evaluate vascular inflammation in inflammatory diseases compared to healthy controls: A pilot study (2013) (0)
The relation between aging, aortic NaF avidity and coronary artery NaF avidity: A NaF PET CT study (2013) (0)
Role of PET/MRI in musculoskeletal diseases (2020) (0)
Contribution of FDG-PET in the detection of pulmonary lymphangitic carcinomatosis (PLC) in patients with primary lung carcinoma (2007) (0)
MINIMIZING MEDICAL FAILURE IN A POTENTIAL ORGAN DONOR POPULATION (1998) (0)
Atherosclerosis in Rheumatoid Arthritis: correlation between FDG and NaF uptake in the aortic wall (2015) (0)
Comprar Positron Emission Tomography · Review Questions for the PET Specialty Exam for Technologists | Ramer, Karen | 9783540938545 | Springer (2010) (0)
4 Instrumentation and Quality Assurance (2013) (0)
Assessment of diagnostic performance of PET/CT in diagnosis of neck lymph node metastases from head and neck cancer (2008) (0)
PET and PET/CT Assessment of Gynecologic Malignancies: Beyond FDG. (2010) (0)
Discrepancy between in vivo cardiac uptake of 18F-NaF, atherosclerotic plaque, and biochemical assessment of calcification (2014) (0)
Dual-time-point FDG-PET/CT: prognostic value of total metabolic tumour volume in patients with recurrent breast cancer (2016) (0)
Diagnosing bone metastasis in recurrent breast cancer: dual time FDG-PET/CT compared to contrast enhanced CT and bone scintigraphy (2015) (0)
FDG uptake, calcification and the global metabolic activity of the aorta: Correlation with normal aging (2006) (0)
Gender uniformity with SPECT images obtained with attenuation correction (AC) and enhanced acquisition methods (1997) (0)
Cardiac involvement from adenocarcinoma of the lung at diagnosis detected by (18)F-FDG-PET imaging. (2008) (0)
29 Neurologic Applications (2009) (0)
Novel global quantitative assessment of the cerebral cortex on FDG-PET for Alzheimer's disease assessment (2011) (0)
Thallium-201Uptake in Lung Cancer (1995) (0)
PET Imaging of Thoracic Disease, An Issue of PET Clinics (2011) (0)
Comparison of PET-FDG and SPECT TL-201 in distinguishing radiation necrosis from tumor recurrence in the brain (1994) (0)
Book ReviewPositron Emission Tomography of the Brain (1983) (0)
Appendix 12 Answers to Chapter 12 (2013) (0)
PET-CT-MRI-Based Cardiovascular Imaging (2019) (0)
12 Brain Neoplasms (2009) (0)
/sup 99m/Tc-MDP uptake in nonsseous lesions (1980) (0)
American Journal of Nuclear Medicine and Molecular Imaging: Editorial Board (2012) e-Century Publishing Corporation. (2012) (0)
Diagnosis of distant recurrent breast cancer: head-to-head comparisons of FDG-PET/CT, contrast enhanced CT, and bone scintigraphy (2015) (0)
Treatment response assessment of Crohn's disease by FDG-PET/CT by a novel quantitative approach (2013) (0)
48. Superiority of FDG PET over bone scan in patients with lung cancer (2003) (0)
Primary cutaneous lymphoma: FDG-PET/CT and its potential applications in monitoring response to treatment (2013) (0)
Role of FDG-PET and FDG-PET/CT in the management of hepatic tumors treating with Yttrium-90 radio-embolization (2019) (0)
FDG-PET findings of paraneoplastic limbic encephalitis (PLE) (2008) (0)
Fourier ventricular amplitude ratio to evaluate atrial septal defect (1985) (0)
Venous thromboembolism: A novel application for 18F-FDG-PET/CT (2014) (0)
PET Atrophy Correction of Wholebrain Metabolic Rates in Aging and Dementia Using Volumetric Analysis of MR Images (1990) (0)
18F-FDG-PET/CT in Radiation Therapy-Induced Cerebellar Inflammation (2022) (0)
Use of PET/MRI in clinical oncology: An update on applications and pitfalls. (2015) (0)
GENDER RELATED DIFFERENCES IN THE OBSERVED REGIONAL MYOCARDIAL DISTRIBUTION OF 99M-TECHNETIUM SESTAMIBI : IMPROVEMENT WITH NONUNIFORM ATTENUATION CORRECTION (1996) (0)
Fluorodeoxyglucose versus Non-Fluorodeoxyglucose PET-Computed Tomography in Less-Explored Domains: An Appraisal. (2022) (0)
15 Non-imaging Procedures and Radionuclide Therapy (2013) (0)
Clinical Uses of Radionuclides: Critical Comparison with Other Techniques (1973) (0)
New observation of early detection of venous thromboembolism by FDG PET/CT in patients with multiple myeloma (2014) (0)
Appendix 5: Answers to Chapter 5 (2013) (0)
7 Central Nervous System Scintigraphy (2013) (0)
The role of FDG PET/CT imaging in the assessment and diagnosis of venous thromboembolic disorders. (2019) (0)
IMPACT OF DUAL TIME POINT FDG PET IMAGING IN THE ASSESSMENT OF SOLITARY PULMONARY NODULES (2008) (0)
The evolving role of PET/CT for prognostication in patients with lung cancer (2014) (0)
MRI based segmentation for accurate calculation of red marrow metabolic activity with FDG-PET imaging (2006) (0)
Pulmonary structural and functional changes associated with increasing age (2007) (0)
FDG PET imaging as a potential modality for detecting atherosclerotic lesions in the major arteries (2004) (0)
The effects of limb laterality and age on the inflammation and bone turnover of the acromioclavicular shoulder joint: 18F-fluorodeoxyglucose and 18F-sodium-fluoride-PET/computed tomography study (2022) (0)
Can FDG-PET imaging accurately differentiate infected from non-infected painful hip prosthesis? (2007) (0)
Differential Diagnosis of Psychotic Disorder with High Creatine Kinase and Subfebrile Fever: A Case Report (2017) (0)
Evolving Role of PET Imaging in Hematologic Malignancies. (2019) (0)
Clinical value of bone scan in the evaluation of low back pain: A retrospective study (1999) (0)
18F-NaF Uptake in Ocular Prosthesis (Implant). (2019) (0)
Evaluation of FDG-PET in staging and recurrence of patients with nasal cavity and paranasal sinus carcinomas (2007) (0)
Metabolic Imaging for Assessing Solitary Pulmonary Nodules (2005) (0)
Sodium Fluoride PET/CT Imaging as a Promising Tool for the Assessment of Coronary Plaque Deposition (2018) (0)
Efficacy of radioimmunotherapy in mantle cell lymphoma (2006) (0)
Correlation of Global Cardiac Microcalcification with CHADS2and CHADS2-VASc Scores in Individuals At-risk for Cardiovascular Disease as Assessed by NaF-PET/CT (2020) (0)
FDG-PET/CT for assessment of temporomandibular joint metabolic activity in rheumatoid arthritis patients and healthy subjects (2019) (0)
Tc-99m Phytate as an Imaging Agent for Lymph Nodes—Reply (1978) (0)
Paclitaxel and Carboplatin in Elderly Patıents with Advanced Non-Small Cell Lung Cancer (2016) (0)
Does the primary breast lesion and the metastatic foci behave differently with regard to FDG uptake over time in dual time point FDG-PET? (2007) (0)
THE ROLE FOR FDG PET IN THE IMAGING OF SKELETAL INFECTION: CORRELATION WITH CLINICAL OUTCOME (1998) (0)
FDG-PET/CT is a valuable diagnostic tool for verifying accelerated atherosclerosis secondary to diabetes mellitus in the large arteries (2016) (0)
CHEST RADIOGRAPH FINDINGS IN PATIENTS WITH PULMONARY EMBOLISM; AN OBSERVATION FROM THE PIOPED STUDY (1993) (0)
Comparison of low dose unenhanced CT, FDG-PET, FDG-PET/CT, and contrast-enhanced CT for the detection of lesions in patients with lung cancer (2009) (0)
PET-PASI score: Utility of FDG-PET/CT in Psoriasis (2020) (0)
[The ECG changes during the performance of hemodialysis using dialysis solution concentrates with different potassium levels in patients with chronic kidney failure and normokalemia]. (1993) (0)
Determination of the lumped constant and the kinetic constants for deoxyglucose and fluorodeoxyglucose in man (1985) (0)
Long Axial Field-of-View PET/CT Could Answer Unmet Needs in Gynecological Cancers (2023) (0)
SEQUENTIAL BLOOD VOLUME STUDIES FOLLOWING ALBUMIN IN-FUSION IN NEWBORN LAMBS WITH HYPOVOLEMIC SHOCK (1977) (0)
Comparison of foot standardized uptake values (SUVs) and metabolic volumetric products (MVPs) in diabetic subjects with neuropathy, charcot joint, and atherosclerosis with those of non-diabetic subjects (2008) (0)
27. Diffuse hypermetabolism in thyroid is not suspicious for malignancy (2003) (0)
Correlation of clinical outcome with FDG-PET based response of non-Hodgkin's lymphoma (NHL) to radioimmunotherapy (RIT) (2008) (0)
Metabolic consequences of pulmonary artery hypertension in the right ventricle as determined by FDG-PET/CT in patients with COPD (2013) (0)
Neoplasm and Infection Scintigraphy (2002) (0)
Can [F]fluorodeoxyglucose positron emission tomography imaging complement biopsy results from the iliac crest for the detection of bone marrow involvement in patients with malignant lymphoma? (2005) (0)
Lung scanning in patients with suspected pulmonary embolism: a decade of PIOPED (1996) (0)
Comparability of quantitative SUV measurement between PET alone and PET-CT on patients scanned consecutively on PET and PET-CT scanners (2006) (0)
NUCLEAR CARDIOLOGY Right and Left Ventricular Volume and Ejection Fraction by Tomographie Gated Blood-Pool Scintigraphy (2006) (0)
Regional Cerebral Metabolic and Structural Changes in Normal Aging and Dementia as Detected by PET and MRI (2021) (0)
14 Thyroid Cancer (2009) (0)
Comprar Breast Cancer Imaging I, An Issue of PET Clinics | Rakesh Kumar | 9781437709643 | Saunders (2010) (0)
FDG-PET Imaging in the Differentiation of Infected from Noninfected Painful Hip Prosthesis (2008) (0)
Feasibility of quantitative assessment of age-related changes in cerebral cortical function and functional volume via a novel semi-automated FDG-PET/CT image analysis approach (2011) (0)
FDG-PET/CT versus CT in local recurrent breast cancer and the standardized uptake value in local and distant recurrent breast cancer (2015) (0)
The promising role for FDG-PET imaging in the management of painful hip prostheses (1998) (0)
Regional Increased Blood Flow in a Case of Post‐Infectious Encephalomyelitis (1976) (0)
PET-based Novel Imaging Techniques with Recently Introduced Radiotracers. (2021) (0)
Evaluation of neonatal hydronephrosis with diuretic renography (1998) (0)
Radioiodinated D1 and D2 dopamine receptor ligands (1992) (0)
Society communications (2007) (0)
Re: Aducanumab-Related ARIA: Paean or Lament? (2023) (0)
Detection and localization of gastrointestinal bleeding sites with scintigraphic techniques (1991) (0)
Off-Target Report on 18F-Sodium Fluoride PET/CT for Detection of Skeletal Metastases in Prostate Cancer (2019) (0)
Pathology detection on medical images based in oriented active appearance models (2010) (0)
Potential role and implications of 18F-FDG-PET/CT imaging in the detection and management of iliopsoas abscess. (2010) (0)
Review of Clinical Applications of Fluorodeoxygluco se- PET/Computed in Pediatric Patients with Lymphoma (2012) (0)
25 Musculoskeletal Tumors (2009) (0)
ssessment of Age-Related hanges in Abdominal Organ Structure nd Function With Computed Tomography nd Positron Emission Tomography (2007) (0)
Appendix 4 Answers to Chapter 4 (2013) (0)
The role of F-18 FDG PET in assessing treatment response in patients with cardiac sarcoidosis (2013) (0)
Correlation of standardized uptake value and its change over time in FDG-PET imaging with the histopathological characteristics of primary breast malignancy at diagnosis (2007) (0)
Retrogenetic models of working memory: Preliminary multi-group analysis. (2019) (0)
Esophageal Scintigraphy in Achalasia and Achalasia4ike Disorders (2006) (0)
Global disease assessment in mesothelioma with FDG-PET/CT: Addressing the shortcomings of the SUV approach (2012) (0)
Single Photon Emission Computed Tomography (2016) (0)
PET: Widening Role Evaluating Infections: Used to detect cancers, positron emission tomography also pinpoints infections and localized inflammatory responses (2010) (0)
Radionuclide Bone Marrow Imaging in Cancer Patients (2012) (0)
What is the optimal duration for gastroesophageal reflux study in pediatrics (2007) (0)
SIGNIFICANCE OF EARLY EXTRACTION IN THE FIRST MINUTE OF Tc-99m MAG3 RENAL TRANSPLANT STUDIES (1998) (0)
ssessment of Age-Related orphological and Functional Changes of elected Structures of the Head and Neck by omputed Tomography , Magnetic Resonance maging , and Positron Emission Tomography (2007) (0)
FDG-PET takes lead role in suspected or proven infection (2007) (0)
Musculoskeletal applications of PET-based quantitative techniques (2021) (0)
Factors that affect gastric emptying rate in children with gastroesophageal reflux study (2007) (0)
Carotid artery atherosclerosis:plaque imaging in the personalized-medicine era (2018) (0)
Magnetic resonance imaging-based partial volume-corrected 18F-sodium fluoride positron emission tomography in the femoral neck. (2020) (0)
The clinical role of FDG-PET in the assessment of olfactory neuroblastoma (2007) (0)
Efficacy of FDG-PET in the detection of malignancy in paraneoplastic neurological syndromes (2007) (0)
Emerging role of radiolabeled nanoparticles as effective diagnostic tools (2014) (0)
Monitoring the Progression of a Calcifying Uterine Leiomyoma: Detection Using 18F-NaF-PET/CT. (2022) (0)
A preliminary study of a novel image analysis methodology for quantification of lung tumor response and lung inflammation post-radiation therapy on FDG-PET/CT (2011) (0)
Clinical applications of PET/MRI in oncology: Opportunities and challenges (2014) (0)
FDG PET findings are predictive of histopathological response after neoadjuvant therapy for esophageal cancer (2006) (0)
Letter from the Guest Editors. (2018) (0)
21 Pancreatic Cancer (2009) (0)
Scintigraphic Appearance of Albuterol‐Induced Inhibition of Hypoxic Pulmonary Vasoconstriction (1994) (0)
PET IMAGING IN HEAD TRAUMA (1992) (0)
Metabolic Tumor Volume on FDG-PET Predicts Clinical Outcomes Following Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer: A Secondary Analysis of ECOG-ACRIN 6668/RTOG 0235 : Locally Advanced Non-Small Cell Lung Cancer (2014) (0)
Comprar Pediatric PET Imaging, An Issue of PET Clinics | Hongming Zhuang | 9781416061120 | Saunders (2009) (0)
FDG uptake and calcification in the large arteries of young patients (2007) (0)
Testicular scintigraphy in the evaluation of the acute scrotum (1997) (0)
Diagnostic value of FDG-PET imaging prior to radio immunotherapy (2008) (0)
Abass Alavi. A distinguished physician scientist and a pioneer in molecular imaging. (2014) (0)
Appendix 11 Answers to Chapter 11 (2013) (0)
Targeted and Functional Imaging (2015) (0)
ASSESSMENT OF THE EFFECTS OF PAIN AND ACUPUNCTURE ON REGIONAL CEREBRAL BLOOD FLOW USING Tc-99M HMPAO SPECT IMAGING (1998) (0)
FDG-PET/CT demonstrates limited efficacy in an animal model of atherosclerosis (2020) (0)
Study on the correlation of clinical neuropathy with metabolic activity (MA) and metabolic volumetric product (MVP) of the diabetic foot (2008) (0)
Temporal lobe hypometabolism in patients with hippocampal atrophy and mesial temporal sclerosis (1998) (0)
Comparison of Tc-99m bone scans with FDG-PET for bone lesion detection (2006) (0)
The effect of aging on atherosclerotic plaque inflammation and molecular calcification: A PET CT imaging study (2013) (0)
Assessing the effects of aging on the spine using FDG-PET with novel quantitative techniques of global assessment (2017) (0)
Emerging role of PET/MRI in Neurology: An update on the current applications and pitfalls. (2015) (0)
Unraveling Vascular Inflammation (0)
Phase I Study of 131-I-Tositumomab Radioimmunotherapy (RIT) in Patients with Relapsed or Residual CD20 Antigen-Expressing B Cell Lymphomas Following Autologous Hematopoietic Stem Cell Transplantation (2014) (0)
Optimal time point to assess aortic atherosclerosis by FDG PET/CT imaging (2013) (0)
The Utility of 18F-NaF-PET/CT in Measuring the Metabolic Activity of Aging Spine: Implications for Osteoporosis. (2023) (0)
A strong but non-specific relation between FDG uptake in the lower extremity veins and Venous Thromboembolism (2015) (0)
FDG-PET as a potential indicator of systemic immune response to various cancers (2008) (0)
Acute effects of repeated electroconvulsive therapy (ECT) on cerebral blood flow assessed by Tc-99m-HMPAO SPECT: a preliminary study (1997) (0)
Quantitative assessment of FDG uptake in thoraco-abdominal muscles, lungs and right ventricle of patients with COPD (2006) (0)
PET in the Management of Hematologic Malignancies (2019) (0)
CAN I-123 REPLACE I-131 FOR IMAGING PATIENTS WITH DIFFERENTIATED THYROID CANCER (DTC)? (1999) (0)
Post-surgical skin inflammation of tumor site in skin cancer patient: How long does it last? (2006) (0)
Mean small bowel metabolic activity decreases with age in adults while maximum overall small bowel and colon metabolic activity increases with age in children (2007) (0)
Reply to: Clinical brain PET research must embrace multi-centre collaboration and data sharing or risk its demise: emphasis should also be placed on the critical role of image analysis schemes (2020) (0)
NaF-PET/CT in multiple myeloma: assessing bone remodeling at baseline in newly diagnosed myeloma patients compared to a healthy control group (2017) (0)
2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography monitoring disease progress in a patient with islet carcinoma of the pancreas. (2002) (0)
Physiologic colonic 18F-FDG uptake in assessing the risk for proximal colorectal neoplasia (2016) (0)
Abstract P043: Correlation Between Blood Pressure And Left Ventricular Metabolism In HIV Individuals With And Without Cocaine Use As Assessed By FDG-PET/CT (2020) (0)
Appendix 13 Answers to Chapter 13 (2013) (0)
18F-FDG-PET/CT in predicting pathologic complete response after neoadjuvant chemotherapy: the early metabolic response is the answer. (2013) (0)
26 Pediatric PET/CT (2009) (0)
Discrepant atherosclerotic disease activity in aging in the aorta and femoral-popliteal arteries demonstrated by FDG-PET/CT imaging (2013) (0)
Comparison of FDG and Florbetapir PET for diagnosing Alzheimer's disease (2011) (0)
Time vs. precision: Optimal method to quantify global atherosclerosis in major arteries with FDG-PET/CT imaging (2013) (0)
Changes in myocardial uptake of F18-fluorodeoxyglucose after chemotherapy in pediatric patients with lymphoma (2007) (0)
Exploring Tumor Biology with Fluorodeoxygluco se (2009) (0)
Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature review (2017) (0)
The effects of RMP-7 on the blood-brain barrier (BBB) permeability as determined by imaging techniques (1994) (0)
Evaluation of FDG-PET imaging in differentiating septic from aseptic painful knee prostheses (2007) (0)
Effects of galactosemia on cerebral glucose metabolism measured by FDG PET (2007) (0)
PET/MRI: Concepts and Clinical Applications (2016) (0)
Local cerebral glucose utilization measured with 18F-2-fluoro-2-deoxyglucose (1978) (0)
Evaluation of the role of aging on quantification of NaF uptake in the shoulder, hip and knee joints (2017) (0)
Quantitative Assessment of Pulmonary Artery Atherosclerosis with 18F- Sodium Fluoride Positron Emission Tomography- Computed Tomography: A Novel Study (2020) (0)
The role of FDG-PET imaging in detecting early Charcot's arthropathy in diabetic patients (2007) (0)
Positron Emission Tomography In Clinical Research and Clinical Diagnosis (1991) (0)
Evolving Role of PET/CT in the Diagnosis and Management of Gynecologic Malignancies (2016) (0)
16 Patient Care (2013) (0)
5 Image Presentation and Computers (2013) (0)
FDG-PET/CT in multiple myeloma: Correlation between SUV and standard prognostic scoring system in multiple myeloma (2016) (0)
Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Prosthetic Joints and Diabetic Foot: A Comparative Perspective with Other Functional Imaging Modalities. (2022) (0)
The effect of glucose load on both cardiac and skeletal muscle FDG uptake (2004) (0)
The effect of receptor state of breast cancer on FDG uptake at dual time point imaging (2007) (0)
Quantification of dual time point FDG-PET/CT in bone lesions in breast cancer recurrence (2015) (0)
The emerging role of positron emission tomography (PET) in the management of photon radiotherapy-induced vasculitis in head and neck cancer patients (2023) (0)
Potential role of FDG-PET imaging in the setting of diabetic neuro-osteoarthropathy: Can it differentiate osteomyelitis from Charcot neuroarthropathy and soft tissue infection? (2007) (0)
22 Gynecologic Tumors (2009) (0)
28 FDG PET in the Evaluation of Infection and Inflammation (2009) (0)
An improved synthesis of 9-[(3)-[F-18]fluoro-1-hydroxy-2-propoxy)methyl]guanine ([F-18]FHPG). (1999) (0)
Role of FDG-PET/CT in assessment and monitoring patients with Primary Cutaneous T-Cell Lymphoma (2015) (0)
Semi-quantitative 18F- NaF-PET/CT in the assessment of bone mineral density: Comparison with dual-energy x-ray absorptiometry (DXA) (2013) (0)
Feasibility of Global Assessment of Bone Metastases in Prostate Cancer with 18F-Sodium Fluoride-PET/Computed Tomography. (2022) (0)
Appendix 15 Answers to Chapter 15 (2013) (0)
FDG-PET imaging in the management of patients with mantle cell lymphoma (2006) (0)
Inflammation, Calcification, and Bone Metabolism in the Tibiofemoral Joint as Early Biomarkers of Osteoarthritis (2022) (0)
The potential value of FDG-PET for the detection of gall bladder cancer or cholangiocarcinoma (2007) (0)
PET/MRI applications in lung cancer (2018) (0)
THE LEVEL OF LUNG N-13 AMMONIA UPTAKE BY PET CORRELATES WITH THE DEGREE OF LEFT VENTRICULAR DYSFUNCTION (1996) (0)
Intermittent fasting in Ramadan in patients on maintenance hemodialysis: Relation to malnutrition, inflammation, body composition and quality of life (2018) (0)
Comprar Pet In Cns Disease, An Issue Of Pet Clinics, Vol. 5-2 | A. Newberg | 9781437719420 | Saunders (2010) (0)
Is Imaging Bacteria with PET a Realistic Option or an Illusion? (2023) (0)
University of Southern Denmark 18F-FDG-PET/CT in measuring volume and global metabolic activity of thigh muscles (2019) (0)
PET and PET/CT in Pediatric Gastrointestinal Oncology (2008) (0)
FDG-PET imaging as a potential indicator of systemic immune response to thyroid cancer (2007) (0)
Pet-Based Novel Imaging Techniques with Recently Introduced Radiotracers (0)
Bone turn-over biomarker: Emerging role of 18F-NaF-PET/CT (2013) (0)
Diabetic control and gastrointestinal function (1982) (0)
Nuclear Medicine Imaging in the Diagnosis of Cardiac Sarcoidosis (2012) (0)
17 Positron Emission Tomography (2013) (0)
Dual time point 18F-FDG PET/CT in patients on suspicion of malignant lymphoma (2014) (0)
11 Therapy Response (2009) (0)
Appendix 8 Answers to Chapter 8 (2013) (0)
CHARACTERISTICS OF REGIONAL LUNG N-13 AMMONIA UPTAKE (1995) (0)
A phase II trial of intraperitoneal photodynamic therapy after debulking surgery for the treatment of disseminated intraperitoneal malignancies (1998) (0)
Comprar Breast Cancer Imaging II, An Issue of PET Clinics | Sandip Basu | 9781437714029 | Saunders (2010) (0)
Graying Population: Role of PET in Age-Related Disorders. (2023) (0)
Effect of aging and smoking on FDG-uptake in atherosclerotic plaques assessed by multiple-time-point PET/CT imaging (2012) (0)
The potential value of dual time point FDG-PET imaging for the detection of noninvasive breast cancers (2007) (0)
Quantitative FDG-PET/CT assessment of alterations in global hepatic metabolism due to cirrhosis (2011) (0)
Special Issue on Antibody Research Call for Papers (2013) (0)
Aortic FDG uptake, segmental correlation with aging and gender (2008) (0)
Metabolic correlates of clinical factors and outcome following acute cerebral infarction (1986) (0)
5 Standardized Uptake Value (2009) (0)
FDG-PET/CT for initial staging of colorectal cancer (2014) (0)
Nuclear medicine technology : review questions for the board examinations (2005) (0)
Serial FDG PET/CT in the diagnosis of suspected lung malignancy (2014) (0)
Metabolic activities of metastatic lesions to the liver as measured by FDG-PET vary considerably depending on the origin of the primary malignancy (2006) (0)
Characterization of unclear findings at FDG-PET/CT in cancer pts (2008) (0)
American Journal of Nuclear Medicine and Molecular Imaging: Editorial Board (2014) e-Century Publishing Corporation. (2013) (0)
Measuring the effects of aging using 18F-sodium fluoride uptake in the spine (2017) (0)
“Visualization” of pain using cerebral 18F-FDG PET/CT following surgical treatment of lumbar disc herniation (2021) (0)
Comparison of left ventricular ejection fraction calculated using attenuation-corrected and non-attenuation corrected images in gated cardiac spect imaging (2004) (0)
11 Genitourinary System Scintigraphy (2013) (0)
Role of dual time point FDG PET imaging in differentiating axillary lesion in breast cancer (2009) (0)
Appendix 17: Answers to Chapter 17 (2013) (0)
Importance of changes in the standardized uptake values in the early and delayed FDG-PET of the primary breast malignancy in predicting axillary lymph node and distant metastases (2007) (0)
EVIDENCE OF MOTOR EFFERENT PATHWAY ACTIVATION IN NORMAL VOLUNTEERS IN RESPONSE TO TRANSCRANIAL MAGNETIC STIMULATION AS SHOWN BY HMPAOSPECT (1996) (0)
Emerging techniques for assessment of multiple myeloma patients with PET/CT using FDG and NaF (2019) (0)
Pelvic lipomatosis detected on bone scintigraphy. (2004) (0)
Molecular Imaging for Investigation of the Pathophysiology of Brain Degeneration and Dementia (2021) (0)
Quantitative FDG-PET parameters in detection and characterization of breast carcinoma (2008) (0)
2 Radioactivity, Radiopharmacy, and Quality Assurance (2013) (0)
Potential Applications of PET-Based Novel Quantitative Techniques in Pediatric Diseases and Disorders. (2020) (0)
Impact of FDG-PET Imaging Versus Conventional Staging Modalities on Staging and Treatment Decisions in Large B-Cell, Follicular, and Hodgkin’s Lymphomas. (2004) (0)
PET will make SPECT irrelevant in 10 years (2005) (0)
FDG-PET/CT in the Assessment of Global Brain Metabolism in Cardiovascular Disease (2020) (0)
THE ROLE OF FDG-PET IMAGING IN DETECTING EARLY RESPONSE TO CHEMOEMBOLIZATION IN HEPATIC COLORECTAL CARCINOMA METASTASES (1996) (0)
Role of Fluorodeoxyglucose-PET in Interventional Radiology. (2022) (0)
15. Fluorodeoxyglucose positron emission tomography of infectious and inflammatory disease (1999) (0)
Quantitative Assessment of Pulmonary Atherosclerosis with FDG PET/CT (2019) (0)
Appendix 10 Answers to Chapter 10 (2013) (0)
PET/CT in management of oncologic patients (2015) (0)
Multiple-time-point FDG-PET imaging as a clinically feasible dynamic imaging method (2013) (0)
Diagnostic value of 18 F-FDG PET in detecting different subtypes of lymphomas by WHO classification (2004) (0)
Role of FDG-PET/PET-CT in evaluation of adrenal lesions in patients with known malignancies (2007) (0)
Comprar PET Imaging of Thoracic Disease, An Issue of PET Clinics | Drew A. Torigian | 9781455710492 | Saunders (2011) (0)
Variable metabolic activity of primary and metastatic site at different organs in lung cancer as measured by corrected SUV of FDG uptake: A new observation (2006) (0)
Methods of PET/CT image analysis for quantification of atherosclerosis in major vessels (2014) (0)
XIV annual meeting of the international society for pediatric neurosurgery, Madrid, 30 September — 3 October 1986 (2004) (0)
Assessment of methods to quantitatively evaluate global synovitis activity with FDG-PET/CT (2017) (0)
Potential of 18F-FDG-PET in the global assessment oflung inflammation (2021) (0)
Exploring the role of FDG-PET in unusual non-Hodgkin's lymphomas (NHL) (2008) (0)
The role of dual-time-point FDG-PET in assessing radiologically suspicious lesions in the contralateral breast in patients with newly diagnosed breast cancer (2007) (0)
Regional variability of atherosclerotic disease in various anatomic segments of aorta as revealed by FDG-PET/CT imaging (2013) (0)
131I Labeled small antibody mimetic VHCDR1-VHFR2- VLCDR3 as a novel tracer for targeting Burkitt's lymphoma in nude mice (2009) (0)
AN AUTOMATED TECHNIOUE FOR VOLUMETRIC MEASUREMENT OF THE BRAIN AND INTRACRANIAL CEREBROSPINAL FLUID SPACES: APPLICATION IN NEUROIMAGING (1989) (0)
In‐111-DTPA‐IgG: A NON‐SPECIFIC POLYCLONAL ANTIBODY FOR IMAGING INFECTION/INFLAMATION (1990) (0)
18F-FDG-PET/CT for assessment of volume and global metabolic activity of the thigh muscles: A CT-based segmentation methodology (2019) (0)
Role of FDG-PET/CT in the management of multiple myeloma and plasma cell dyscrasia (2014) (0)
The combination of functional and anatomical imaging improves has a high accuracy in the detection of carcinoid tumors (2006) (0)
Using FDG and NaF PET/CT imaging to investigate the relationship between inflammation and microcalcification in the aorta (2019) (0)
Automatic analysis of molecular PET/CT images using cognition network technology: A novel concept (2010) (0)
JAMA Peer Reviewers for 2003 (2017) (0)
PET-CT-MRI Applications of Musculoskeletal Disorders, Part II (2019) (0)
Role of Molecular Imaging with PET/MR Imaging in the Diagnosis and Management of Brain Tumors. (2022) (0)
The non-invasive detection of pedal osteomyelitis in the diabetic population: A comparison between FDG-PET, MRI, and conventional radiography (2007) (0)
Functional Molecular Imaging in the Assessment of Brain Tumors (2015) (0)
Alternative quantification of global lung glycolysis using volumetric FDG PET/CT parameters in lung cancer patients treated with radiotherapy (2015) (0)
Can standardized uptake value (SUV) characterize brain tumors on FDG PET Scan (1998) (0)
In Memoriam: David E. Kuhl, MD 1929-2017. (2017) (0)
Multimodality Molecular Imaging: A Futuristic Outlook (2014) (0)
Referee Acknowledgement for 2014 (2015) (0)
Reduced metabolism in the cerebellum of obstructive sleep apnea (OSA) patients using FDG-PET (2012) (0)
Can FDG-PET/CT replace conventional imaging technologies in suspected recurrent breast cancer? A prospective head-to-head comparison of dual time point FDG-PET/CT, contrast enhanced CT, and bone scintigraphy (2015) (0)
SU‐FF‐I‐45: Effects of Patient Positions On PET Tumor Volume Assessment in Lung Cancer (2005) (0)
RADIOISOTOPIC SCINTIGRAPHIC LOCALIZATION OF LOWER GI BLEEDING SITES: COMPARISON WITH ARTERIOGRAPHY AND SIGMOIDOSCOPY (1982) (0)
FDG-PET in the evaluation of plexiform neurofibromatosis (2007) (0)
Measurement of global 18F-sodium fluoride uptake: a marker of disease activity in large joints with degenerative joint disease (2016) (0)
Temporal profile of FDG uptake at multiple time points (up to 6-7 hours) in malignant lesions and normal organs in patients with lung carcinoma (2007) (0)
Sacroiliac joint asymmetry with regard to inflammation and bone turnover: assessment by FDG and NaF PET/CT (2018) (0)
FDG-PET imaging tackles large arteries with atherosclerosis (2007) (0)
Quantitative assessment of global and regional inflammation in patients with Crohn’s disease by FDG PET/CT: An inter-reader and intra-reader agreement evaluation study (2014) (0)
Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials (2022) (0)
Role of FDG-PET in the diagnosis of recurrent and metastatic lesions of malignant testicular tumors (2007) (0)
Obesity correlated with high degree of FDG uptake in the aorta in population with normal lipid profile of same age group (2006) (0)
The effects of age, density and menopausal state on FDG uptake in normal breast tissue and interactions among them (2008) (0)
Different predictive value of 18F-FDG-PET and MRI imaging in detecting local disease recurrence of low and high grade pediatric primary brain tumors (2006) (0)
Visualization of atherosclerotic plaques using targeted molecular imaging (2015) (0)
Sarcopenia and Myositis Revisited: Emerging Role of Fluorine-18 Fluorodeoxyglucose PET in Muscle Imaging. (2023) (0)
PET-FDG Imaging in Metastatic Breast Cancer Treated with High Dose Chemotherapy and Stem Cell Support (1998) (0)
Detection of Thrombophlebitis with In In-labeled Anti-Fibrin Antibody : Preliminary Results 1 (2006) (0)
Potential clinical role of FDG-PET in assessing primary (PPL) or secondary lymphomas (SL) of the parotid gland: Comparison with benign and physiological uptake (2007) (0)
MAGNETIC RESONANCE IMAGING HYPERINTENSITIES IN ALZHEIMER'S DISEASE. AUTHOR'S REPLIES (1991) (0)
30 Cardiac PET and PET/CT (2009) (0)
In Memoriam: Hussein M. Abdel-Dayem, MD 1934-2017. (2017) (0)
Education and Research Foundation: Investing in the Future (1996) (0)
Appendix 18: Answers to Chapter 18 (2013) (0)
Effect of tube feeding on gastric emptying rate in children with scintigraphic gastroesophageal study (2007) (0)
FDG PET/CT in multiple myeloma: changed FDG uptake in the brain of patients receiving high dose chemotherapy (2017) (0)
University of Southern Denmark Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation (2019) (0)
Assessment of Crohn’s disease activity by FDG-PET/CT through a novel quantitative approach (2011) (0)
Normal Patterns of Regional Brain FDG Uptake in Normal Aging (2016) (0)
PET Imaging in Oncologic Patients (2001) (0)
Dual time-point FDG-PET imaging to distinguish tumor from normal and inflammatory sites in the head and neck. (1999) (0)
Glucose metabolism in plaque macrophage: Molecular mechanism for FDG-PET imaging of atherosclerosis (2009) (0)
Degree of FDG and MDP uptake in femoral arteries: Changes with age (2006) (0)
Recent Advances in Imaging With Pet, Ct, and Mr Techniques (2020) (0)
Detection of coronary inflammation (2019) (0)
Dual time point imaging in differentiating post biopsy inflammation from invasive tumor in patients with newly diagnosed breast cancer (2007) (0)
Regarding “18F-GP1, a Novel PET Tracer Designed for High-Sensitivity, Low-Background Detection of Thrombi” (2017) (0)
The importance of early and delayed FDG-PET imaging in evaluating inflammatory atherosclerotic changes within the arterial wall (2013) (0)
The value of FDG-PET/CT imaging in the assessment, monitoring, and management of COVID-19 (2023) (0)
Functional imaging of the brain with/sup 18/F-fluorodeoxyglucose (1980) (0)
Radiographic and scintigraphic evaluation of lung transplant patients (1995) (0)
Regional analysis of the effects of age and weight on the spine with 18F-sodium fluoride tracer (2017) (0)
The potential value of dual-time-point FDG PET in detecting extra-axillary lymph node and distant metastasis of newly diagnosed breast cancer (2007) (0)
Evolving Role of PET-guided Interventional Oncology (2019) (0)
The testicular metabolic and volumetric changes in the adolescent and young adults (2007) (0)
9 Respiratory System Scintigraphy (2013) (0)
PET/CT-based radiation therapy for lung cancers: Pros and cons of proton vs. photon radiation therapy (2018) (0)
he Evolving Role of tructural and Functional Imaging in ssessment of Age-Related Changes in the Body rew (2007) (0)
Comparison of FDG-PET, FDG-PET/CT, contrast-enhanced CT (CECT), and low dose non-contrast CT (NCCT) imaging of diffuse large B-cell lymphoma (DLBCL) (2008) (0)
Applications of PET in Radiation Oncology (2019) (0)

This paper list is powered by the following services:

Other Resources About Abass Alavi

en.wikipedia.org

What Schools Are Affiliated With Abass Alavi?

Abass Alavi is affiliated with the following schools:

Abass Alavi's Academic­Influence.com Rankings

Abass Alavi's Degrees

Why Is Abass Alavi Influential?

Abass Alavi's Published Works

Published Works

Other Resources About Abass Alavi

What Schools Are Affiliated With Abass Alavi?

Abass Alavi's AcademicInfluence.com Rankings